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Every year there are approximately 9 million bone fractures in the United States, and 30% 
of these require an internal fixation device to help heal. Currently, the gold standard for fixation 
devices relies on the use of metals because of their high mechanical properties and bioinertness. 
However, metal implants often require a second surgery to remove them because they cause 
stress shielding and metal ion leaching. Current bioresorbable fixation devices on the market have 
poor mechanical properties and are limited to use in non-load-bearing applications (i.e. maxillo-
facial fractures). As such, there remains a gap in the fracture fixation devices on the market, where 
a bioresorbable, high-performance device could provide the mechanical stability of metal devices, 
while safely degrading in vivo. The present study focuses on the development of such a device 
by fabricating a composite material containing both long-fiber and particle reinforcement. Using 
novel processing techniques, a composite consisting of PLLA fibers, HA nanorods, and PCL ma-
trix was fabricated and had a bending modulus and strength of 9.2 Gpa and 187 MPa, respectively. 
To increase the mechanical properties, statistically designed experiments (DOE) were employed 
to home in on an ideal material composition of the composite material, resulting in the use of SF 
fibers, HA nanowhiskers, and a PLA matrix. The final composite possessed a bending modulus 
and strength of 21.3 GPa and 531 MPa, respectively. This composite material was formed into a 
curved device and contained screw holes, resembling current metal fixation plates. These devices 
underwent an accelerated 8-week in vitro degradation  
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study, in which the samples lost a total of 5 wt%. Additionally, cell proliferation studies showed 
cells increase proliferation through 7 days of culturing on the plates, and a cell viability assay 
revealed the samples have good in vitro biocompatibility after 14 days of culturing. Overall, the 
mechanical properties, degradation trend, and biocompatibility of the fabricated composites in this 
study show great promise for future use as a degradable load-bearing bone fixation device, in 
which in vivo studies will be needed to verify the efficacy of the composite material as a bone 
fixation device.
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CHAPTER 1: INTRODUCTION 
1.1. ORTHOPEDIC INJURY 
The topic of orthopedic injury pertains to a wide range of ailments relating to the muscu-
loskeletal system [1]. Such ailments include injuries to ligaments, tendons, cartilage, and, most 
notably, bone tissue. While some injuries will naturally heal (i.e. a minor ankle sprain or bone 
fracture), often times  an orthopedic implant is required to help the affliction heal properly, with 
over 30% of bone fractures requiring internal fixation devices to help heal [2]. Orthopedic trauma 
fixation remains one of the fastest growing medical markets in the United States, with the rate of 
orthopedic surgery increasing from 17.9% to 24.2% of all surgeries performed from 2001 to 2011 
[3], but fracture fixation techniques have been present for centuries [4]. This rapid growth is lead-
ing the orthopedic fixation market to grow to $41.2 billion annually by 2019, making it one of the 
largest markets in the medical field [5]. Such rapid growth owes itself to two major factors:  the 
ever-increasing population, especially the aging baby boomer generation, and the technological 
advances in surgeries, allowing for more reliable surgeries to be performed. Despite this rapid 
growth and ever-increasing demand, the technology for fracture fixation devices has remained 
relatively stagnant in recent decades. As previously mentioned, orthopedic injury treatment en-
compasses a wide range of musculoskeletal disorders/injuries, but of particular interest is a sub-
set of orthopedic surgeries known as internal fracture fixation, which is expected to account for 
over $9 billion of the market by 2020 [6]. Technological advances in the field of fracture fixation 
has been relatively lacking for the past few decades, in large part because of the limitations in 
materials available for fixation in tandem with the unique properties of bone tissue that make it 
rather difficult to heal properly.  
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1.2. BONE TISSUE 
Bone tissue is a natural composite material composed of a polymeric material with a ce-
ramic reinforcement [7], as shown in Figure 1.1 [8]. The polymeric component of bone is type I 
collagen which comprises approximately 30-40% of the bone tissue, and the remaining 60-70% 
is inorganic mineral phase, which is mainly hydroxyapatite [9]. The composite nature of bone 
enables it to possess unique mechanical properties, such as a relatively high modulus, high 
strength, and high toughness. The presence of hydroxyapatite (elastic modulus = 140 GPa [10]) 
allows for bone to have a high stiffness, providing structural integrity for the body, and the pres-
ence of collagen increases the strength and toughness of bone [11], decreasing the occurrence 
of brittle failure. The ratio of collagen and hydroxyapatite can vary throughout the body, leading 
to a range of modulus and strength values of 7-25 GPa [12, 13] and 80-160 MPa, respectively 
[14]. Bone tissue is also known to be highly vascularized [15], providing easy access to necessary 
nutrients and allowing for relatively rapid healing when the fractured segments are set properly. 
By comparison, unvascularized tendon or cartilage tissue takes significantly longer to fully heal 
because nutrients is not as readily available as it is with bone [16], remaining one of the biggest 
challenges in the field of tissue engineering. Owing itself to this ability to quickly heal, bone tissue 
is constantly undergoing remodeling [7], in which old tissue is resorbed and new tissue is synthe-
sized in response to various stimuli, often times mechanical. This change in mechanical stimuli is 
typically caused by either increasing/decreasing physical activity or bodyweight over a long period 
of time. As such, when mechanical stimuli increase, the bone mass increases, and when the 
mechanical stimuli decrease, the bone mass decreases. This is the reason astronauts lose sig-
nificant bone mass during extended trips in space [17]. This remodeling is a vital function for the 
body, and enables the bone tissue to remain healthy and fully functional over the life of a patient, 
but it poses a unique challenge when trying to heal a bone using an internal fixation device [18], 
which will be discussed in more detail below. 
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Figure 1.1: The hierarchical structure of bone tissue, where mineralized collagen fibrils comprise larger 
fibers, which make up fiber bundles and form the osteons that make up the structure of bone  [8]. 
 
1.3. CURRENT BONE FIXATION SOLUTIONS 
As previously mentioned, bone fracture fixation devices are implants used to help support 
bones during fracture heeling [2]. Several different types of orthopedic fixation devices have been 
developed and are broadly classified as plates, screws, or intramedullary rods/nails [19], as pic-
tured in Figure 1.2 [20]. As seen in the figure, plates and rods are typically used in conjunction 
with screws to anchor fractured bone fragments in place.  
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Figure 1.2: The three main bone fixation devices, including intramedullary rods, screws, and plates  [20]. 
 
Current bone fixation devices primarily rely on the use of metals, particularly elec-
tropolished stainless steel and titanium, because of their high stiffness and strength and bioinert-
ness. These metal implants provide sufficient structural integrity to hold the bone fragments to-
gether for proper healing, however they also promote what is known as stress shielding. Due to 
the exceedingly high moduli of stainless steel and titanium (210 GPa and 110 GPa, respectively), 
the loading/stress on the bone gets transferred from the bone to the implant [21]. As a result of 
the decreased loading, the bone surrounding the implant begins to undergo resorption overtime 
(shown in Figure 1.3 [22]) and can lead to implant loosening and future fractures.  
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Figure 1.3: Stress shielding in a long bone after implant removal, where the decrease in bone mineral 
density is evident in the cortical bone [22]. 
 
Along with stress shielding, metal fixation devices are known to cause chronic metal ion 
leaching, leaking ions into nearby tissue and can cause gradual tissue necrosis and inflamma-
tion/irritation [23]. Both of these long-term factors can lead to the need for a second surgery to 
remove the implant, adding to patient cost and discomfort [24]. Titanium has gradually become 
the preferred material over stainless steel because of the lower elastic modulus and higher bio-
compatibility [25]. Due to the aforementioned drawbacks of using metals as fixation devices, there 
is a pressing need to explore new bone fixation materials [26].  
To remedy the drawbacks of metal fixation devices, there have been resorbable fixation 
devices developed that allow the device to slowly degrade in vivo as the bone heals, leaving only 
patients’ natural tissue after a couple of years. Such devices almost exclusively use polylactic 
acid (PLA) or polylactic-co-glycolic acid (PLGA). These polymers are aliphatic polyesters that are 
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known to safely degrade in vivo during the course of 1-2 years [27, 28], making them very attrac-
tive materials for bone fixation applications. However, the modulus and strength of these polymers 
are relatively low, with values of ~3 GPa and ~50 MPa, respectively [29, 26]. As such, fixation 
devices made from PLA/PLGA are limited to use in non-load-bearing applications, which typically 
entails maxillofacial fractures, as their stiffness and strength cannot provide adequate support for 
the healing of load-bearing fractures (i.e. the long bones of the arms or legs). Despite their exclu-
sive use in non-load-bearing applications, polymeric devices still need to be thicker than their 
metal counterparts to compensate for this disparity in mechanical properties [26]. Figure 1.4 
shows a relatively minor difference in thickness between titanium and resorbable fixation devices, 
but in other examples the thickness of polymeric fixation devices can be over 1 mm thicker than 
their metal counterparts [30]. This increase of ~1 mm in thickness provides ample support for 
healing bone, but can cause the implant to be visible in areas where skin is relatively tight on the 
bone (i.e. on the forehead) [31]. However, this drawback is only temporary, as the implant will be 
completely resorbed over time. 
 
Figure 1.4: Examples of thicknesses of various fixation device systems, showing the necessary increase 
in thickness required for resorbable devices to be feasible for fracture fixation [26]. 
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Despite the modulus of the current metal fixation devices being the primary culprit for 
causing stress shielding, the modulus of the implant material does not necessarily cause stress 
shielding [32]. Rather, it is the overall stiffness of the implant that causes stress shielding of the 
surrounding bone. Unlike the modulus, which is an intrinsic property of a material, the stiffness is 
size- and shape-dependent [33]. For example, PLGA and titanium implants can have the same 
stiffness values depending on the size and shape of the implants. Bending stiffness is described 
as the amount of force needed to deflect a material a certain distance and is typically reported as 
N/m or N/mm. For this reason, there has been work done on making metallic hip implants that 
have the same stiffness as a femur despite being made from metals [34], which would drastically 
reduce the occurrence of stress shielding while maintaining the structural advantages of metals. 
However, the size restrictions (i.e. the thickness of bone plates) have hindered such designs from 
being made for internal fixation devices. There have, however, been hypothetical implant materi-
als made using finite element analysis to see how a metal plate could be designed to avoid stress 
shielding [9]. An example of such a material had an internal fixation device designed to be “stiff-
ness-graded” [35], in which the stiffness of the material decreased either through the thickness or 
along the length of the material, as shown in Figure 1.5. Both materials designed in the study 
showed a significant decrease in stress shielding, but there has still been no such material that 
has been made and tested in vitro or in vivo, which is why much of the interest in this field has 
shifted to the development of composite materials that would provide more desirable mechanical 
properties. 
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Figure 1.5: Example of stiffness-graded bone fixation plates that have been designed using finite element 
analysis for the purpose of decreasing stress shielding [35]. 
 
1.4. COMPOSITE MATERIALS 
To this point, the pros and cons of two different material choices have been highlighted, 
where metals offer great mechanical properties at the cost of long-term biocompatibility and pol-
ymer-based materials offer excellent long-term biocompatibility but with insufficient mechanical 
properties for load-bearing bone fractures. Such a conundrum presents the opportunity to utilize 
composite materials to provide the benefits of both materials. Composite materials contain two or 
more components, a reinforcement and matrix material, to offer unique benefits that monolithic 
materials cannot produce [36]. Composites are found in nature (i.e. bones are a natural composite 
of collagen and hydroxyapatite) and humans have been fabricating composite for thousands of 
years [37]. Composites generally offer the benefits of each constituent material, where typically 
one material will provide a high stiffness/strength and another material will provide a high tough-
ness and a low density [38]. To this end, there are two broad groups of composite materials: long-
fiber- and particle-reinforced composites, seen in Figure 1.6 [36].  
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Figure 1.6:The two general types of composites, particle-reinforced (discontinuous) and long-fiber-rein-
forced (continuous) composites [36]. 
 
As the name suggests, long-fiber-reinforced composites contain a reinforcement material 
that is largely one-dimensional (i.e. the diameter is negligible compared to the length of the fiber). 
While not always the case, long-fiber reinforced composites typically contain highly stiff fibers 
bound together with a relatively weak matrix [36]. Perhaps the most well-known of such compo-
sites are carbon fiber-reinforced composites, where high-modulus carbon fibers are bound to-
gether with epoxy. This combination creates a material with a stiffness and strength exceeding 
most metals [39], while retaining a low overall density and high toughness. This high toughness 
stems from the mode of failure of composite materials, where the composite should either fail due 
to fibrous failure or matrix failure [36]. If fibrous failure occurs, the fiber breakage happens one-
by-one, so the composite does not fracture catastrophically. If matrix failure occurs, then the fibers 
serve as a means to block the propagation of the crack (crack deflection) and require a failure of 
the fiber-matrix bond to be pulled from the matrix (fiber pullout). Also of importance, long-fiber-
reinforced composites can be unidirectional (as the schematic shows in Figure 1.6), a mesh, or a 
laminate [40]. A laminate is a composite that contains multiple layers of a long-fiber-reinforced 
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composite, where the plies can be organized in different ways to exhibit different mechanical 
properties. When fibers are primarily oriented in one direction, the composite will have high me-
chanical properties in the direction of the fibers, however the plies in laminates can also be orga-
nized to fabricate a bulk material that mimics isotropic materials (i.e. quasi-isotropic) [41].  
Particle-reinforced composites consist of a matrix material reinforced with three-dimen-
sional particles of various shapes and sizes [36]. Particle reinforced composites allow similar ben-
efits to those of long-fiber-reinforced composites (i.e. high stiffness and strength), but typically to 
a lesser degree. This stems from the particles being more difficult to align and the reinforcement 
efficiency of the particles [42]. Particle reinforced composites often contain particles that are either 
randomly oriented or only partially aligned, which is known to cause a decrease in mechanical 
properties along the axis of interest when compared to fully aligned particles [43]. Additionally, 
the increase in mechanical properties caused by the addition of particles in highly dependent on 
the reinforcement efficiency of the particle [44]. This reinforcement efficiency parameter, which 
will be discussed in greater detail in a later chapter, is a unitless value that is highly dependent 
on the aspect ratio (length-to-diameter ratio) of the particle [45]. If the particle is largely spherical, 
there will be a negligible increase in the modulus of the matrix material, however the strength and 
toughness should increase as a result of the aforementioned crack deflection phenomenon seen 
in composites. However, if high-aspect-ratio particles are used as reinforcement particles, then 
the modulus of the final composite can be significantly higher than that of the matrix material [46]. 
This can be further increased if particle alignment (or partial alignment) is achieved. 
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1.5. RESORBABLE LOAD-BEARING FIXATION DEVICES 
1.5.1. COMPOSITE MATERIALS 
Due to the unique properties desired from bone fixation devices, particularly high strength 
and stiffness while being resorbable in vivo, composites have been extensively researched to fill 
the void of products currently on the market [47]. As mentioned in the previous section, compo-
sites are a class of material that consists of a combination of any two or more materials, leaving 
nearly endless possibilities of materials to be made. With regards to bone fracture fixation, how-
ever, the composites being researched are almost exclusively composed of materials that are 
already FDA approved or are proven to safely degrade in vivo [48]. As such, composites made 
for this purpose are typically bioceramic-reinforced polymeric composites. 
One of the earliest attempts at making a bioresorbable composite for load-bearing bone 
fixation devices, and perhaps still the most successful attempt, came from Shikinami et al. [49], 
who sought to improve the mechanical properties of PLA by reinforcing it with hydroxyapatite 
through the use of novel fabrication methods. Poly-L-lactic acid (PLLA) and HA were coprecipi-
tated out of a suspension, extruded, and hot compression molded to form a composite where the 
matrix polymer, PLLA, was reinforced with microparticles of HA. Furthermore, the processing pro-
cedures enabled them to partially align the PLLA polymer chains, further increasing the mechan-
ical properties along the axis of interest. After testing multiple formulations with varying amounts 
of HA present, Shikinami et al [49]. was able to fabricate a composite with a flexural modulus and 
strength of 12.3 GPa and 267 MPa, respectively. However, due to processing limitations and poor 
impact strength, the formulation with the modulus of 12.3 GPa could not be considered for future 
use, so they elected to use a composite with a modulus and strength of 9.1 GPa and 270 MPa, 
respectively, for future studies. These values represent an increase of ~3 and ~5 times the mod-
ulus and strength, respectively, of non-reinforced PLLA. Additionally, the resulting composites 
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could be easily molded and machined into commonly used bone fixation device shapes, as seen 
in Figure 1.7 [49]. Despite this increase, they determined the material still would not be suitable 
for load-bearing applications, but rather could be used for maxillofacial and mandibular fractures, 
as the mandible is considered to be a bone that undergoes moderate loading [50]. However, it 
was proven in a long-term in vivo study [51] that these composites safely degraded within the 
body over the course of several years and provided adequate stability for bone healing. 
 
Figure 1.7: The PLLA/HA composite bone fixation devices fabricated by Shikinami et al., where they were 
able to fabricate screws, plates, and rods [49]. 
 
Using a similar concept, but different materials, Coskun et al. [52] fabricated a composite 
using poly(3-hydroxybutyrate) (P3HB) and its copolymers with 3-hydroxyvalerate (HV) (PHBV8 
and PHBV22) as a matrix material and HA as a reinforcement material. P3HB is a natural polymer, 
so their hope was to fabricate a composite material with an improved degradation profile and 
similar mechanical properties as previously achieved. By simply injection molding the 
P3HB/PHBV8/PHBV22-HA composite resin into the desired shapes, a modulus and strength of 
5.4 GPa and 78 MPa, respectively, were achieved. The results are not as promising as previously 
reported values, but the authors noted that this showed the feasibility of using natural polymers 
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for such an application and that higher properties could have been achieved if processing tech-
niques similar to that of Shikinami et al. were employed. 
Ahmed et al. [53] used compression molding processing to fabricate composites of PLA 
reinforced with high-aspect-ratio phosphate glass (PG) fibers. The composites that contained uni-
directional PG fibers achieved a modulus and strength of 11.5 GPa and 130 MPa, respectively, 
while randomly oriented PG fibers yielded composites with a modulus and strength of 10.5 GPa 
and 120 MPa, respectively. Also, the authors noted that the composites exhibited a rapid loss in 
mechanical integrity when submerged in deionized water, which indicates even faster degradation 
in vivo.  
Sun et al. [44] fabricated a three-phase resorbable composite consisting of PLLA, poly-
caprolactone (PCL), and HA using novel processing methods. Briefly, PLLA fibers were run 
through a melt mixture of PCL and HA inside a pultrusion die, and then the coated fibers were hot 
compression molded to bind the components into a dense composite. Since the melting temper-
ature of PCL is lower than that of PLLA (60 °C compared to 160-170 °C [54]), during the com-
pression molding step the PCL matrix polymer was melted, while the PLLA retained integral fi-
brous form. This results in a composite that has both long, continuous fiber and particle reinforce-
ment. The pultrusion used here proved to partially align the HA particles within the matrix, achiev-
ing a final flexural modulus and strength of 8.7 GPa and 97 MPa, respectively, while showing 
remarkable toughness. 
Charles et al. [55] fabricated what is known as a self-reinforced composite comprising 
PLLA fibers and biomimetic HA. Biomimetic HA refers to a form of HA produced via unassisted 
calcium phosphate nucleation in modified simulated body fluid (m-SBF). By increasing the con-
centration of calcium and phosphate ions in in SBF, hydroxyapatite will naturally precipitate over-
night. As such, Charles et al. submerged PLLA fibers in m-SBF, where a uniform coating of HA 
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formed on the surface of the fibers. The fibers were subsequently heated up to their melting point 
and pressed into dense composite bars. Using PLLA fibers rather than PLA resin to fabricate such 
a composite takes advantage of the increased alignment of polymer chains within fibers when 
compared to polymer pellets [56]. This increase in chain alignment, in tandem with the uniform 
HA nucleation, resulted in composites with a bending modulus and strength of 9.7 GPa and 135 
MPa, respectively.  
With the mechanical properties of PLA-based composites seemingly reaching a plateau, 
Perrone et al. [57] fabricated bone fixation composites using the natural polymer silk fibroin (SF). 
SF is a natural polymer produced by the Bombyx mori (B. mori) silkworm and is known to safely 
degrade in vivo [58]. Additionally, SF fibers are known to have some of the highest mechanical 
properties of any natural polymer, with a tensile modulus and strength of ~19 GPa and ~800 MPa 
[59]. Despite these properties, it has had minimal use in the field of orthopedics due to the difficulty 
of processing the material, stemming from the fact that SF does not melt like the other polymers 
discussed thus far [60]. Furthermore, SF naturally has a thin coating of sericin, which serves to 
bind the fibers together when making a cocoon, however this elicits an inflammatory response 
and must be removed prior to silk being used in the body. For these reasons, Perrone et al. 
developed unique processing methods to fabricate SF-based fixation devices. Briefly, sericin was 
removed from SF fibers via boiling in a solution of sodium bicarbonate, yielding degummed SF. 
The SF was then dissolved in a lithium bromide (LiBr) solution, and solvent casting was used to 
fabricate the various shapes previously mentioned for bone fixation devices. The resulting SF 
devices had a bending modulus of 2.7 GPa [61], but a bending strength was not reported.  
Strictly related to the modulus of a bioresorbable composite, the best composite for bone 
fixation applications thus far has come from Yuka et al. [62] In a novel approach, PG fibers were 
soaked in a mixture of dianhydro-D-glucitol bis[di(lactoyl)methacrylate] macromer, 2-hydroxyethyl 
methacrylate (HEMA), and dibenzoyl peroxide. The coated fibers were then placed in an oven to 
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cure at 100 °C for 1 h, yielding a dense composite material. The resulting material possessed a 
modulus and strength of 15-20 GPa and 140-200 MPa, respectively, and they also failed via fi-
brous failure. While this is the highest reported stiffness thus far, reaching the higher end of the 
range for natural bone (7-25 GPa), the authors noted that the composites degraded far too rapidly 
and lost most of their structural integrity after only a few weeks in vivo. 
1.5.2. DEGRADABLE METALS 
Due to the lack of success in fabricating bioresorbable composites for fracture fixation, 
metals that safely degrade in vivo have been investigated as well [63], as such materials would 
combine the mechanical properties of metals, yet safely degrade after the bone is healed. The 
most notable of such metals is magnesium (Mg) [64], which has been proven in literature to safely 
degrade in vivo in small quantities and also has an elastic modulus and strength of 45 GPa [65] 
and 200-250 MPa [66], respectively. When magnesium degrades in vivo, the byproducts are mag-
nesium hydroxide (Mg(OH)2) and hydrogen gas (H2) [64]. Mg(OH)2 is a chemical that is commonly 
used in medicine as an antacid [67] and can be safely processed by the liver and kidneys [68], 
and H2, in small quantities, is a harmless gas that is expelled from the body via the lungs [69]. 
Both of these chemicals are intrinsically safe in vivo, however problems arise during in vivo deg-
radation of Mg because of the large quantities needed to make a feasible fixation device and 
because of the inherently fast degradation of Mg [70]. This rapid degradation of causes a massive 
buildup of H2 gas at the site of the implant and causes severe irritation and inflammation. 
The quick degradation of Mg in vivo can be slightly remedied by alloying the material with 
other metals [71]. An example of such an alloy is LAE442, which contains 90 wt% Mg, 4 wt% Li, 
4 wt% A1, and 2 wt% rare earth elements, a combination that elicits a decrease in grain size [68]. 
The reduced grain size leads to a more controlled degradation rate, thus reducing the degradation 
rate. Similar effects have been seen when alloying magnesium with zinc (Zn) [72]. Despite the 
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successful attempts in reducing the degradation rate, these alloys have yet to be clinically used 
because of the trace amounts of metal ions that are proven to have relatively poor biocompatibility 
(i.e. aluminum is known to be unsafe in vivo [73]). Additionally, composites have been made using 
Mg in the form of magnesium alloy wires (MAW) [74]. An example of such a composite was formed 
by alternately stacking PLA and MAW and thereafter hot pressing the materials into a dense 
composite [75]. These composites achieved a bending strength of 190 MPa, however the bending 
modulus was not reported.  
1.6. RESEARCH OBJECTIVES 
As outlined to this point, there remains a gap in the clinically-available materials for ortho-
pedic bone fixation devices. Currently, the gold standard for bone fracture fixation devices primar-
ily relies on the use of metals, namely stainless steel and titanium, because they possess high 
mechanical properties to ensure the fracture is stable for the duration of fracture healing and are 
bioinert (they largely do not elicit harmful effects in vivo). However, these materials are known to 
cause stress shielding and metal ion leaching over time, and, as such, often require a second 
surgery to remove the implant. Conversely, the devices already on the market that safely degrade 
in vivo do not have adequate mechanical properties and are limited to use in non-load-bearing 
applications. While there has been an abundance of work done to try to fabricate materials that 
would satisfy the needs of an ideal bone fixation device, ultimately there has been no success 
thus far.  
As such, the focus of this research is to create a material that successfully fills this gap, 
creating a device that has mechanical properties suitable for load-bearing applications while re-
maining totally resorbable in vivo. Specifically, this material will have a modulus matching that of 
natural bone (7-25 GPa [12]), where the goal will be to match, but not exceed, the upper end of 
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that range, as having a stiffness that is too high will cause stress shielding. Additionally, the ma-
terial will have a strength exceeding that of natural bone (80-160 MPa [11]), and there is no con-
crete limit to the desired strength, as the high strength of current fixation devices has no harmful 
effects on bones.  
To accomplish this goal, a composite material will be made consisting of three phases, 
which will provide the modulus, strength, and toughness required of a bone fixation device. The 
composite will contain either PLLA or SF fibers, HA particles, and either a PCL or PLA matrix. 
These materials were chosen based on their reported mechanical properties [59, 56, 76, 10, 29] 
degradation times in vivo [58, 44], and because they are all already FDA approved [77, 78, 79, 
80]. For this application, either SF or PLLA fibers will be employed to increase the stiffness and 
strength of the composite in the longitudinal direction; either PLA or PCL will be used as a binding 
polymer to “glue” the composite together; and HA particles will be used to increase the stiffness, 
strength, and toughness of the matrix material, and subsequently increase these values in the 
final composite as well. Unique HA particles will be used here to increase the reinforcement effi-
ciency and further improve the mechanical properties of the composite versus using mostly spher-
ical particles. The presence of HA should also make the material intrinsically more biocompatible 
than metal devices because HA is known to be osteoconductive [81]. Through the use of unique 
composite processing techniques and novel HA particle synthesis, the fabricated composites will 
show great promise for future use as load-bearing, resorbable fixation devices.  
The overall objective of this research can be separated into three specific aims: (1) estab-
lishment of processing parameters for utilizing a solvent-based pultrusion system for developing 
three-phase composites, (2) incorporation of degummed silk fibroin reinforcement and polylactic 
acid matrix for improved mechanical properties, and (3) fabrication of functional fixation devices 
and in vitro analyses to ensure the composites are feasible for future in vivo studies. The following 
chapters delve into details about the fulfillment of these objectives.   
 18 
CHAPTER 2: FABRICATION OF A THREE-PHASE BIORESORB-
ABLE COMPOSITE FOR BONE FRACTURE FIXATION  
2.1. INTRODUCTION 
Orthopedic injuries and diseases are one of the most common health complications in the 
world, and in 2012 the Centers for Disease Control and prevention (CDC) estimated the United 
States spends $224 billion annually on orthopedic-related injuries; this cost includes any initial 
treatment/surgery as well as secondary surgeries and other complications [2]. Bone fractures are 
one of the most common orthopedic complications, and serious fractures may need to undergo 
fixation surgeries to heal properly [18]. 
Fixation surgeries involve the implantation of plates/screws to anchor a fractured bone to 
aid in the healing process [82]. Currently, bone plates and screws on market are made of high-
performance metals, such as titanium and stainless steel, due to their high elastic modulus of 
over 100 GPa as well as their relative inertness in the body.  On the other hand, bones themselves 
are a composite of the organic polymer collagen and hydroxyapatite resulting in a tough material 
with an elastic modulus of 7-25 GPa [83]. This vast difference in moduli between the current 
fixation devices and natural bone causes stress shielding near the implanted fixation device. 
Since the metal implants have such a high modulus, any load imparted on the bone is transferred 
through the metal implant. Due to this sudden decrease in average loading on the bone, the bone 
surrounding the implant will degrade over time, which can lead to further fractures or require a 
second surgery to remove the implant [84] [85] [86] [87]. As such, there has been great interests 
in the use of biodegradable polymer-ceramic composites that have an elastic modulus matching 
that of natural bone. 
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Typically, biodegradable fixation devices are a composite of a polymer reinforced with 
calcium phosphate ceramic particles [88]. Poly-L-lactic acid (PLLA) is a commonly used polymer 
for orthopedic applications because it is a relatively stiff biodegradable polymer and is already 
FDA approved [89].  Zhang et al. utilized a co-precipitation method to make an HA-reinforced 
PLLA composite yielding an elastic modulus of 3.6 GPa and a tensile strength strength of 155 
MPa [90].  Shikinami and Okuno were able to create a PLLA/HA-particle-reinforced composite via 
a compression molding process with a flexural modulus of 12 GPa, but the HA content in the 
composite was too high, making it difficult to process and leading to low toughness [91].  Using a 
similar processing approach, Furukawa et al. fabricated a composite of PLLA and calcined HA, 
but only achieved a modulus of 7.8 GPa.  However, a high bending strength of 280 MPa was 
obtained [92].  Although showing great promise, these two approaches provide the highest re-
ported elastic modulus of a HA-particle-reinforced PLLA matrix composite.  Recent research has 
been shifted into finding a feasible fiber-reinforced biodegradable composite for bone fixation de-
vices [93].  One such composite made by Aydin et al. used PLLA/HA composite fibers as a long-
fiber reinforcement in a PLLA matrix [94]. To accomplish this, they suspended hydroxyapatite 
nanorods within a solution of PLLA and chloroform, dried the resultant suspension, and extruded 
the dried product into continuous fibers. With this method they were able to attain a Young’s 
modulus of 4.1 GPa and a tensile strength of 70 MPa.  The lack of significant improvement in this 
study is primarily due to defects created by using a PLLA/HA composite fiber.  To remedy this, 
Sun et al. created a composite with an HA-filled PCL matrix reinforced with long PLLA fibers [95].  
With this, they were able to create a tough composite with a flexural modulus of 8.7 GPa and a 
strength in the range of 100-150 MPa.  Furthermore, Charles et al. created a self-reinforced com-
posite of PLLA and HA having a flexural modulus of 9.7 GPa and a strength of 125 MPa, which 
is nearly the most favorable combination of modulus and strength for this application found in 
literature. 
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This study aims to build upon previous methods for making biodegradable fiber-reinforced 
composites and solve the problem of compromising strength for modulus and vice versa.  This 
was approached via a process of dip coating PLLA fibers in a PCL/HA suspension, pulling the 
dried fibers through a flattening die, and finally hot pressing the fibers into a dense composite bar.  
Using this suspension dip coating method allows for a uniform coating of HA and PCL mixture on 
the surface of PLLA fibers, while hot pressing the long PLLA fibers with a PCL and HA nano-rod 
matrix leads to a tough composite with a high modulus.    
2.2. MATERIALS AND METHODS 
2.2.1.  MATERIALS 
The following materials were purchased from Fisher Scientific:  calcium nitrate tetrahy-
drate (Ca(NO3)2∙4H2O, certified ACS), di-ammonium hydrogen orthophosphate ((NH4)2HPO4, 
99%), ammonium hydroxide (NH4OH, certified ACS plus), and methyl ethyl ketone (MEK, certified 
ACS).  The poly-L-lactic acid (PLLA) fibers were generously supplied by Teleflex Medical, and 
the polycaprolactone (PCL), Mn = 80,000 was bought from Instamorph.  The surfactant cetyltri-
methylammonium bromide (CTAB) (98%) was bought from MP Biomedicals.  The pultrusion die 
and the compression mold, seen in Figure 2.1, were machined by the machine shop at the Insti-
tute of Material Science. 
 21 
 
Figure 2.1: The pultrusion die (a) and the compression mold (b) used to fabricate the composites during 
this stage of the study. 
 
2.2.2. HA SYNTHESIS AND SURFACE TREATMENT 
The HA was produced via a wet precipitation method seen previously involving the drop-
wise addition of one solution to another.   To start, 47.216 g of calcium nitrate tetrahydrate 
(Ca(NO3)2∙4H2O) was added to 180 mL of deionized water (DiW).  6 mL of ammonium hydroxide 
(NH4OH) was added to the solution to raise the pH to 11.  174 mL of DiW was further added to 
the solution, marking the completion of solution 1.  Solution 2 was made by first adding 15.84 g 
of di-ammonium hydrogen orthophosphate ((NH4)2HPO4) to 300 mL of DiW.  150 mL of NH4OH 
was added to raise the pH to ~11, and 190 mL more DiW was added to dissolve any precipitates 
formed and finalize solution 2.  Solution 2 was then added drop-wise to solution 1 under vigorous 
stirring.  Once completed, the final HA suspension was boiled for 3 h.  The HA was then washed 
with DiW until no ammonia remained in the suspension.  Once thoroughly washed, the synthe-
sized HA was dried over night at 150 °C and then ground into a fine powder using a SPEX mill 
(SPEX 8000 Mixer/Mill) for 15 minutes in a steel canister with alumina milling balls, which resulted 
in approximately 18 g of HA powder [86]. 
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A quaternary ammonium salt was chosen as the HA surfactant based on previous studies 
showing its great dispersant properties while showing little to no toxicity in vivo [87].  To start, the 
HA slurry previously mentioned, before washing with DiW, sat with no stirring for 10 minutes to 
allow HA to settle.  A small amount of supernatant was decanted, leaving an approximate HA 
concentration of 30 g/L.  Next, a 15 mL solution of 0.066 g/mL of CTAB in MEK was added to the 
HA slurry and stirred vigorously for 1 h.  To finish the coating process, the slurry sat with no stirring 
at 50 °C overnight.  Once the surface treatment was completed the HA was washed, dried, and 
crushed, as previously mentioned.   
2.2.3. PULTRUSION PROCESS AND COMPRESSION MOLDING 
To make the long fiber reinforced composites, pultrusion was used to coat the PLLA fibers 
with PCL and HA using a suspension of PCL and HA to dip coat the PLLA fibers.  To start, a 2 
wt/vol% (gPCL/mLMEK) solution of PCL in MEK was made by allowing the PCL to completely dis-
solve in MEK heated to 50 °C.  The solution was heated only to expedite the dissolving of PCL, 
so once completely dissolved, heat was removed and HA was added at concentrations ranging 
from 0 to 15 wt/vol% (gHA/mLMEK) of the total solution.  Higher concentrations of HA in solution 
were tested, but the resulting composites were too brittle to successfully complete the subsequent 
processing needed to make the dense composite samples.  The HA suspensions were sonicated 
to ensure the HA was evenly dispersed throughout the suspension and there was minimal ag-
glomeration.  Generally, the HA/PCL/MEK suspensions was sonicated for 10 min over ice and 
then stirred vigorously for 5 min.  This process was repeated until a stable suspension of HA was 
made, which usually occurred after 4 to 5 cycles.  For this study, suspensions with HA concen-
trations of  5, 7.5, 10, and 15 wt/vol% (gHA/mLMEK) were used for the dip coating and pultrusion 
process and a solution of just PCL in MEK was used as a control. 
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Once a stable suspension was made, the pultrusion system was set up as seen in the 
schematic in Figure 2.2.  As depicted in the figure, the PLLA fibers were pulled through the 
HA/PCL/MEK suspension so HA and PCL stuck to the fibers, and then the fibers are run through 
the pultrusion die, which is used to flatten the fiber bundle into a ribbon shape.  This die squeezes 
the suspension evenly throughout the fiber bundle, and subjects the outer layer to a shear stress 
that helps to align the particles.  The coated fibers were then collected on a spool so they could 
be coated a second time using the same system.  This double coating method was employed to 
maintain an adequate HA:PCL ratio, as well as help coat the fibers more homogeneously.  As 
previously mentioned, increasing the HA content is the best way to increase mechanical proper-
ties in the final sample, but during the experimental process it was found that a suspension con-
taining too much HA (i.e. more than 20 wt% of HA in MEK) ended up being clumpy, containing 
non-homogeneously dispersed HA in the sample.  For this reason, it was determined that coating 
the PLLA fibers twice with a suspension containing relatively less HA would create a better coating 
on the fibers.  So, the PLLA fibers were dip-coated twice with the HA/PCL/MEK suspension. 
 
Figure 2.2: A schematic of the processing steps used to make the composites for this study, showing the 
dip-coating, pultrusion, and fiber consolidation steps.  
 
After the second coating process was complete the PLLA fibers were consolidated on a 
metal frame by wrapping the fibers around the frame 160 times and subsequently hot pressed 
 24 
into the final composite bar.  These fibers were then heated in the compression mold inside the 
Carver Laboratory Press and heated to 75 °C, which is high enough to melt the PCL, but not high 
enough to melt PLLA, which has a melting temperature greater than 160 °C.  Once heated to 
75 °C, the mold was then pressed in the same manner as practiced by Sun et al. [96]  Briefly, the 
mold was uniaxially pressed until a pressure of 450 MPa was reached and then held for 15 min.  
At this point, the mold was cooled to room temperature and the samples were removed for testing. 
The mold used was designed to make specimens comply with ASTM D790 standards, which state 
the sample must be at least 1.6 mm thick, at least 12.7 mm wide and have a span-to-thickness 
ratio of at least 16.   
2.2.4. CHARACTERIZATION 
X-ray diffraction (XRD) and Fourier transform infrared spectroscopy (FTIR) were utilized 
to check for phase purity of the HA.  Also, both surface-treated and non-surface treated HA were 
examined using XRD and FTIR to ensure the presence of the surfactant on the HA while making 
sure the surfactant did not affect the phase purity of the HA.  The XRD examination was conducted 
using Bruker D2 Phaser X-ray diffractometer (XRD) with a copper target.  Powder diffraction pat-
terns were collected over Bragg angles ranging from 5° to 85° with a step size of 0.02 and a 
scanning rate of 1.00 s per step.  The FTIR spectra were acquired using the Specac Quest Dia-
mond ATR accessory over the wavenumber range of 4000 to 400 cm−1. The FEI Tecnai T12 
scanning transmission electron microscope (STEM) was used to determine the morphology of the 
HA nanorods. 
Three-point bending tests were performed to determine the flexural modulus and strength 
of the final samples.  An Instron Model 1011 was used to acquire the flexural.  For testing, a 
support span of 45 mm and a cross head speed of 12.5 mm/min was used, which is in compliance 
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with ASTM-D7264 [97]. For each composition, six samples were tested to provide meaningful 
statistical data for the tests. 
Young’s modulus of PLLA fibrils was determined using the TA Instruments Q800 dynamic 
mechanical thermal analysis (DMTA) testing machine.  The samples were loaded in the tensile 
testing clamps by gluing both ends of the fibers between small pieces of paper and gripping onto 
the paper in the tensile clamps.  The samples were then stretched at a force ramp rate of 0.01 
N/min until they yielded.   
A TA Instruments Q500 thermogravimetric analysis (TGA, TA Instruments) was used to 
determine the weight percent of HA in the composites.  To ensure consistency, two small sections 
of two samples from each composition were tested.  During TGA testing, the samples were heated 
up to 800 °C at a rate of 15 °C/min, providing the weight percent of HA, which was then converted 
to volume percent, using the following nominal densities for HA, PCL, and PLLA, respectively:  
3.156 g/cm3, 1.145 g/cm3,and 1.290 g/cm3 [98] [99] [100].   
To determine the amount of PLLA in each sample, the fibers were stretched to a length of 
1.5 m, cut off and massed.  With this, a mass per meter of the fibers was calculated.  Given the 
known length of PLLA fibers in each sample and known denier of the PLLA fibers, the amount of 
PLLA per sample was calculated.  The composite samples are dense and are presumed to have 
negligible porosity, so the remaining mass fraction, after calculating the mass fraction of HA and 
PLA, is assumed to be the PCL phase in the composite. 
The efficacy of the quaternary salt surfactant cetyltrimethylammonium bromide in dispers-
ing HA particles in a PCL-MEK solution was evaluated.  The HA without surface treatment was 
used as a control. For this, a 10 wt% suspension of HA in MEK/PCL was made for both surface-
treated and non-surface-treated HA.  After completing 5 cycles of the sonication and stirring as 
previously described, the suspensions were monitored for 10 min to observe any settling of HA in 
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the suspension with the HA height at time t (ht) being compared to the initial HA height (h0).  For 
each surface treated and non-surface treated group there were 3 samples observed to assure 
consistency. 
A JEOL 6330F scanning electron microscope (SEM) was used to observe the morphology 
of the PLLA fibers prior to the pultrusion process.  To image the finished composite samples a 
FEI Teneo LVSEM was used.  Both PLLA fibers and composite samples were coated with gold 
palladium (SEM coating unit E5100, Polaron Instruments Inc.) prior to imaging and were observed 
at an accelerating voltage of 5 kV. 
2.2.5. STATISTICAL ANALYSIS 
Results from the study of surfactant efficacy and three-point bending tests were statisti-
cally analyzed using two-way analysis of variance (ANOVA) and expressed as mean ± standard 
deviation. Statistical significance was defined as p < 0.05. 
2.3. RESULTS 
2.3.1.  HA SYNTHESIS AND CHARACTERIZATION 
Figure 2.3 shows the XRD and FTIR data for the HA synthesized for preparation of the 
composite.  In Figure 2.3a, the peak positions and relative intensities of the powder diffraction 
pattern match well with the standard HA pattern, confirming that pure HA is formed [101]  In the 
FTIR spectra, the peaks at 560 and 1,000 cm−1 correspond to the phosphate (PO4
3−) functional 
group, the peaks at 1,500 and 3,400 cm−1 indicate the presence of H2O, and the peak at 3,500 
cm−1, which is masked by the peak at 3,400 cm−1, corresponds to hydroxyl groups (OH−).  Com-
paring the spectra for both surface treated and non-surface treated HA, it is apparent that the 
CTAB surface-treatment step does not affect the purity of the synthesized HA.  Nevertheless, the 
 27 
presence of the surfactant is apparent based on the observation of peaks in the spectra at 2,850 
and 2,950 cm−1, which corresponds with the C–H bonds found in the alkane chain of CTAB.   
 
Figure 2.3: The XRD spectra (a) of the HA showing the surface treatment wit h CTAB does not affect the 
HA crystal structure and the FTIR spectra (b) confirming the presence of CTAB.  
 
The morphology of the synthesized HA is shown in Figure 2.4.  These particles have a 
nanorod structure with a mean length of 70.2 nm and standard deviation of 23.0 nm and a mean 
width of 12.4 nm with a standard deviation of 2.8 nm, giving an average aspect ratio of ~6.   
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Figure 2.4: TEM image of the HA nanorods used as the particle reinforcement phase in the composites.  
 
2.3.2. PLLA FIBER CHARACTERIZATION 
Figure 2.5 shows the morphology of individual PLLA fibers comprising the yarn used to 
make the composite.  Analysis of SEM images reveals the PLLA fibers have a mean diameter of 
17.27 µm with a standard deviation of 0.69 µm.  The DMTA tensile tests revealed that the average 
Young’s modulus of the PLLA fibrils is 8.09 GPa with a standard deviation of 1.2 GPa. 
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Figure 2.5: FESEM image of individual PLLA fibrils, showing the diameter of 17 ± 0.69 µm.  
 
2.3.3. SURFACE TREATMENT 
The settling of HA in the HA/PCL/MEK suspension over time is plotted in Figure 2.6, where 
the y-axis is ht/ho representing the current height (ht) of the HA sediment at a time t relative to the 
original height (ho) of the HA sediment in the beaker.  As clearly seen, the non-surface treated HA 
settles in the suspension at an asymptotic rate and levels out at less than half of its original height.  
However, the HA surface treated with CTAB consistently remains nearly at its original height for 
the entire 10 min of the test.  It is worth noting here that Figure 2.6 includes error bars for the data, 
but they are obscured by the data points because the sample variations were very low for each 
data point. 
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Figure 2.6: Shows the settling of the HA in the HA/PCL/MEK suspension over a period of 10 minutes, 
which is the approximate time needed to dip-coat the PLLA fibers in the solution. Note that error bars are 
present in this plot, but they are covered by the plot points because the distribution was so small.  
 
2.3.4. MECHANICAL PROPERTIES OF THE COMPOSITE 
The flexural modulus and strength as a function of HA volume percent (φHA) in the final 
composite are shown in Figure 2.7.  Both flexural modulus and strength appear to increase as 
φHA increases until about 15 vol%, and beyond that the modulus and strength decrease with fur-
ther increase of HA content.  The flexural moduli of the final composites range from 6.7 GPa to 
9.2 GPa.  At 15 vol% the flexural modulus and strength were 9.2 GPa and 187 MPa, respectively, 
which is on the lower end of the modulus of natural bone but much higher than the strength of 
natural bone. [102]  As displayed by the error bars in Figure 2.7, this high modulus and strength 
are both statistically significantly higher than the other sample compositions tested in this study.  
The high toughness of the composite is reflected in Figure 2.8, where after being subjected to 
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mechanical testing, they showed no signs of brittle failure.  In comparison, the composite contain-
ing 23 vol% HA resulted in a brittle failure, and a modulus and strength of 6.7 GPa and 135 MPa, 
respectively. 
 
Figure 2.7: A plot of the flexural modulus and flexural strength as a function of φ HA of the composites. 
 
 
Figure 2.8: A lateral view of a composite sample with a high vol% of HA, showing the brittle nature (a) and 
a lateral view of a composite bar with the optimal HA vol% showing there is no brittle failure and t he 
material has exceptional toughness (b). 
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2.3.5. COMPOSITE COMPOSITION  
 Figure 2.9 are FESEM images of a composite sample with 15 vol% HA showing the lon-
gitudinal cross section (a) and the transverse cross section (b).  Figure 2.9a shows the long PLLA 
fiber reinforcement with the PCL and HA coating applied to the fibers.  The transverse cross 
section shows a uniform distribution of fibers with no voids and very little matrix agglomeration 
within the sample.  It is worth noting here that any apparent debonding or delamination seen in 
the images was due to the cutting process to prepare the samples for FESEM imaging, but is not 
present in typical composite samples. Table 2.1 shows the contributions of each component to 
the overall composition of the composite where the final HA vol% values of 0, 4, 9, 15, and 23 
vol% correspond to values of wt/vol% of HA in the dip-coating suspension of 0, 5, 7.5, 10, and 15 
wt/vol% (gHA/mLMEK), respectively.  Based on this data in tandem with the mechanical data, it is 
concluded that the optimal composition of this composite with regards to mechanical properties 
is when there is 15 vol% HA, 4.8 vol% PCL, and 80.2 vol% PLLA.  
 
Figure 2.9: FESEM images showing the longitudinal (a) and transverse (b) morphologies of the final com-
posite material. 
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Table 2.1: Lists the contributions of each component to the final composition of each composite made. 
 
 
2.4. DISCUSSION 
PLLA was chosen as the long fiber reinforcement because it is known to be a relatively 
stiff biodegradable polymer that is FDA approved [89].  The fibers provided by Teleflex Medical 
have a Young’s modulus of 8.09 GPa.  Along with adding to the stiffness of the final composite, 
the long fiber reinforcement makes a composite with superior mechanical properties, especially 
excellent toughness via fiber pullout and crack deflection [103].  Also, these PLLA fibers have a 
relatively small diameter, which is known to help increase mechanical properties due to better 
alignment of the polymer chain as well as the increased surface area available for bonding to the 
matrix polymer [93] [104].  PLLA and PCL are known to be very compatible polymers for compo-
site preparation [105].  The attraction between the polymers stems from the hydrogen bonds 
made possible between the the ketone functional group in the PCL and the end chain carboxyl 
groups in the PLLA.  Another factor contributing to the bonding between the PCL and PLLA is the 
constriction of the PCL around the PLLA caused by the cooling that takes place after the com-
pression molding.  This constriction is caused by the differences in thermal expansion of the two 
polymers, which causes PCL to constrict to a greater extent than PLLA upon cooling.  Increased 
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surface area of the PLLA fibers leads to a better transfer of the load from the matrix to the fiber 
as well as greatly decreased crack propagation. The PCL used in this study has a number aver-
age molecular weight (Mn) of 80,000, adding to the toughness of the matrix [106] [107].  It is well 
documented that increasing the molecular weight of a polymer typically leads to an increase ulti-
mate tensile strength and strain to failure, which leads to a tougher material with fewer crack 
formations at low strains [108].  Such high molecular weights of PCL are seldom used in similar 
composite applications due to its high melt viscosity.  However, the process of coating the PLLA 
fibers in this case relies on the use of solubilized PCL, rather than the melted form of PCL. This 
difference in processing reduces the viscosity by several orders of magnitude, enabling the use 
of high molecular weight PCL [95].    
Rod-shaped HA nanoparticles served as the second reinforcement in the current compo-
site.  Hydroxyapatite is the natural mineral phase in bone, so it provides a biodegradable rein-
forcement that is inherently osteoconductive and degrades at a similar rate as the rate that new 
bone is formed.  In addition, Yu-Liang et al. found that the presence of hydroxyapatite orthopedic 
implants significantly increased the healing rate of bone, and an increase in HA crystallinity helped 
sustained healing over a long period of time [109].  Hydroxyapatite can exist in various morphol-
ogies, but a rod shape was desired here as the shear stress in the pultrusion die can help align 
the HA in the composite [88].  The pultrusion die is shaped so that the PLLA fiber bundle is flat-
tened into a ribbon, and this flattening process creates a shear stress on the matrix-coated fibers 
that ultimately partially align the HA particles.  This is another inherent benefit of using a suspen-
sion to dip-coat the fibers.  The alternative to using a suspension is to use a melted compound of 
PCL and HA to coat the PLLA fibers. However, the HA particles tend to form more spherical, 
micrometer-size agglomerates in the melt, leading to a decrease in the surface area to volume 
ratio of the HA, which greatly hinders load transfer from the matrix to the particle reinforcement 
[110]. Also, the agglomerations can lead to processing issues, particularly during the hot pressing 
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step where these agglomerations can lead to inconsistences in HA dispersion within the compo-
site. In contrast, the use of the HA/PCL/MEK suspension allows for the coating of PLLA fibers 
with more well dispersed, individual HA nanorods in suspension.  This helps the HA particle retain 
its morphology which aids in partial alignment of the HA nanorods through the pultrusion process.  
Similar to the bonding between PCL and PLLA, the bonding between the HA and PCL matrix 
hinges on hydrogen bonding between the HA and PCL. [95]  These hydrogen bonds are formed 
between the hydroxyl and phosphate groups in the hydroxyapatite and the ketone group in the 
PCL.  This is another reason why the aspect ratio is important, as the higher surface area to 
volume ratio in a high aspect ratio particle will increase these interactions and strengthen the bond 
between the particle and the matrix.  Also, the thermal constriction imparted on the HA by the 
PCL plays a roll in the bonding between the PCL and HA. 
An important processing step is the double dip-coating of the PLLA fibers with the 
HA/PCL/MEK suspension.  This was utilized to aid in the homogeneity and quality of the coating 
while increasing HA content in the final composite.  HA is known to have a Young’s modulus 
ranging from 40 to 150 GPa; due to this significantly higher Young’s modulus relative to the PLLA 
and PCL, it is important to increase the HA volume percent in the sample as much as possible 
[95] [111]. Meanwhile, it is also important to maintain a sufficient ratio of PCL to HA.  As the 
binding polymer, PCL is required to transfer the load to the HA nanorods and PLLA fibers. If there 
is an insufficient amount of PCL, or too much of the reinforcement particles, the matrix can no 
longer provide this load transfer [93].  Since the solubility of PCL in MEK is finite and plateaus 
near 2 wt% of PCL in MEK, the HA:PCL ratio cannot be maintained by simply increasing the 
concentration of both components in the suspension.  Also, increasing the HA content in the sus-
pension beyond 15 wt% creates a near gel with significant HA agglomerations, making the dip-
coating process inconsistent.  For these reasons, the PLLA fibers were dip-coated twice with 
relatively less concentrated suspensions.  The less concentrated suspensions combined with the 
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use of the surfactant ensure a homogeneous coating of non-agglomerated HA nanorods on the 
PLLA fibers. 
Although this double-dip coating method improves the HA:PCL ratio, it is presumed that 
the decline in mechanical properties beyond 15 vol% of HA in the composite is the result of ex-
cessive nanorod reinforcement.  The HA nanorods are the brittle phase of the composite, so 
beyond 15 vol% the overall composite becomes significantly more brittle, which is shown by the 
decrease in flexural modulus and strength as well as the brittle failure observed in Figure 2.8a.  
As previously mentioned and shown in Table 2.1, there is a notable decrease in the overall PCL 
volume percent in the sample, which is contrary to what is required for the PCL to effectively 
transfer the load to the particle reinforcement. The decrease in PCL content stems from the dip-
coating process only being capable of coating PLLA fibers with a finite amount of the 
HA/PCL/MEK suspension.  Since the PLLA fibers can only adsorb a certain amount of suspension 
at a time, increasing the HA content while keeping the same amount of PCL in the suspension 
will cause a decrease in the amount of PCL attained from dip coating.  This decrease in PCL 
content indicates that high volume percentages of HA in the sample will not be properly coated 
by PCL, hindering the formation of a consistent interface between PCL and HA, which contributes 
to the sudden drop in mechanical properties at high volume fractions of HA.  Ideally, the PCL 
content would increase to account for an increase HA content, but the dip-coating process pro-
hibits this as there is a finite amount of PCL that can be dissolved in MEK.  In addition, it is known 
that increasing the viscosity of the matrix polymer will increase the probability of voids in the final 
composite, so the addition of HA may have contributed to an increase in void volume fraction 
[112]. Parnas explains that increasing particle volume fraction in a matrix results in the increase 
in the viscosity of the matrix, possibly by more than an order of magnitude.  Moreover, increasing 
the amount of nanoparticles in the matrix will increase the agglomeration rate of the particles, so 
even with a thorough sonication and stirring process, excess HA nanoparticles in the suspension 
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could lead to agglomeration.  For this reason, it is reasonable to hypothesize that greater than 15 
vol% HA in the composite will make the PCL/HA matrix more susceptible to voids and HA ag-
glomeration, greatly hindering the mechanical properties of the final composite.   
The present study shows evidence of the possibility of a biodegradable composite material 
being used for load bearing bone fixation within the body, however more studies are needed to 
confirm this.  Such studies include a degradation study in which the rate of degradation of the 
composite is studied, as well as the how the degradation affects the mechanical properties over 
time.  The application of this material requires it to be functional in the body for at least a year, so 
mechanical tests will need to be done at set time points during a degradation study to ensure the 
mechanical properties are sufficient for bone fixation.  Also, fatigue testing will be an important 
step moving forward, as it is likely this composite material would undergo cyclic loading within the 
body.   
2.5. CONCLUSIONS 
In the present study, a high modulus biodegradable composite was successfully made 
comprising a low-melting temperature polymer matrix, a long, tough fiber reinforcement, as well 
as a stiff bioceramic nanorod reinforcement.  The long fiber reinforcement consisted of PLLA 
fibers supplied by Teleflex Medical, while the ceramic nanorods were synthesized hydroxyapatite 
nanorods.  The composites were made using a pultrusion process in which PLLA long fibers were 
coated in a PCL and HA suspension and were subsequently hot compression molded into a dense 
composite.  The final composites had a flexural modulus of 9.3 GPa, which surpasses the lower 
range of natural bone, as well as a flexural strength of over 180 MPa, which significantly sur-
passes that of natural bone.  The use of a surfactant to make a stable HA/PCL suspension to coat 
the PLLA fibers combined with dip-coating the fibers twice ensured a homogeneous coating of 
HA/PCL on the PLLA fibers with minimum agglomeration.  As seen in a sample after flexural 
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testing, the composites exhibit great toughness and no brittle failure, indicating its great potential 
to be used as a bone fixation device.  Future work will aim to increase the flexural modulus further 
through the use of high aspect ratio and single crystalline HA, which should significantly increase 
the alignment of the HA as well as the load transferring for the small particle reinforcement and, 
subsequently, modulus of the composite. 
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CHAPTER 3: INCORPORATION OF SILK FIBROIN FIBER REIN-
FORCEMENT AND POLYLACTIC ACID MATRIX FOR IM-
PROVED MECHANICAL PERFORMANCE 
3.1. INTRODUCTION 
There have been many researched materials that are able to safely degrade in vivo, but 
their mechanical properties typically fall short of what is required for a load-bearing fracture. [51] 
As such, composite materials have been investigated to provide better mechanical support than 
degradable polymers alone. An example of such a composite was made by Zhang et al. and 
consisted of polylactic acid (PLA) in addition to hydroxyapatite particle reinforcement. [113] Using 
an in situ-precipitation method, Zhang et al. created a composite with a Young’s modulus of 3.6 
GPa and a strength of 155 MPa, which is neither strong nor stiff enough for load-bearing applica-
tions. The best results thus far using a polymer matrix reinforced with bioceramic particles came 
from Shikinami et al. [114] Granules of PLLA with uniformly-distributed HA microparticles were 
hot compression molded to make HA-reinforced PLLA composites in this study. The resulting 
composite bars had a bending modulus and strength of 9.1 GPa and 270 MPa, respectively. 
Despite showing the best properties for such a composite, the composites still left much to be 
desired with regards to bending stiffness for use as a load-bearing implant To overcome the rel-
atively poor mechanical properties of polymer-based degradable materials, degradable metals 
have been investigated as well, such as magnesium. [115] Such materials have been shown to 
have mechanical properties similar to bone, however magnesium has been shown to release 
hydrogen gas when degrading in vivo and causes localized inflammation, indicating the need for 
further improvements to make viable degradable fixation devices. Most recently, Heimbach et al. 
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produced a composite containing both biodegradable long-fiber reinforcement and particle rein-
forcement. With this formulation, the composite material achieved a bending modulus of 9.2 GPa 
and a bending strength of 187 MPa while showing remarkable toughness [56].  
Silk fibroin (SF) has been proven to be a degradable polymer with superb mechanical 
properties in tension. [116] In the clinical setting and in literature, silk has been shown to be great 
for use as sutures and tissue engineering scaffolds due to mechanical properties that are superior 
to most other degradable polymers. However, SF has not been previously used to make a high 
performance dense composite in the field of biomaterials. With this in mind, the present study 
investigates the use of SF as the primary reinforcement material in composites made for load-
bearing fixation applications. Using procedures similar to those outlined in previous work, meth-
ods for creating high performance composites were developed with the aid of a design of experi-
ments (DOE), with further work focusing on the use of HA particle reinforcement in tandem with 
SF fiber reinforcement.  
3.2. MATERIALS AND METHODS 
3.2.1. MATERIALS 
The following materials were purchased from Fisher Scientific:  calcium nitrate tetrahy-
drate (Ca(NO3)2∙4H2O, ACS certified), ammonium phosphate dibasic ((NH4)2HPO4, ACS certified), 
methyl ethyl ketone (MEK, ACS certified), and ammonium hydroxide (NH4OH, certified ACS plus). 
Cetyltrimethylammonium bromide (CTAB, ≥ 99%) was purchased from Sigma Aldrich. Dichloro-
methane (DCM, stabilized with amylene, ≥ 99.8%, for analysis) was purchased from Arcos Or-
ganics. Both poly-L-lactic acid (PLLA) and silk fibroin (SF) fibers were generously supplied by 
Teleflex Medical Inc, and polycaprolactone (PCL, Mw = 80,000) was purchased from Instamorph. 
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3.2.2. HA SYNTHESIS AND SURFACE TREATMENT 
Hydroxyapatite nanorods were synthesized via a wet precipitation method as previously 
described. [56] Briefly, 188.86 g of Ca(NO3)2∙4H2O was dissolved in 720 mL deionized water 
(DiW), where 24 mL of NH4OH was added. Next, 696 mL DiW was added to dissolve the resulting 
precipitate, completing the formation of solution 1. To make solution 2, 63.36 g of (NH4)2HPO4 
was dissolved in 1200 mL of DiW.  600 mL of NH4OH was added to solution, and subsequently 
760 mL of DiW was added to dissolve the resulting precipitate, concluding solution 2. Next, solu-
tion 2 was added drop-wise to solution 1, and, upon completion, boiled for 3 hours. Once cooled, 
the HA nanorods formed were surface treated to ensure even distribution and minimal aggrega-
tion in the dip-coating suspension, as previously described. [56] Briefly, the supernatant of the 
resulting suspension of HA particles from procedure previously outlined was poured off until a 
final HA concentration of ~3 g/dL was reached (final volume of ~2.5 L). Next, 4 g of CTAB was 
suspended in 60 mL of DCM and quickly added to the HA suspension under vigorous stirring. 
The suspension continued stirring for 2 h, and then was left to sit overnight at 60 °C to aid in the 
surface treatment. Following the surface treatment, the HA was washed with DiW 5 times to re-
move the NH4OH and dried at 150 °C overnight. Based on these previous studies the final parti-
cles take the shape of nanorods with a final length, width, and aspect ratio of 70 nm, 12 nm, and 
6, respectively. [56] 
3.2.3. DESIGN OF EXPERIMENTS  
Many materials were considered for the development of high performance bioabsorbable 
composites, with the final list of materials being SF fibers, PLLA fibers, PLA matrix, PCL matrix, 
and HA nanoparticles. These materials were selected because they have been shown in literature 
to safely degrade in vivo and are all already FDA approved materials [117, 118, 119, 120]. Due 
to the many different materials used and possible formulations, a design of experiments (DOE) 
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was utilized to assess the effect of key variables in the processing of the composite on the 3 
mechanical properties (i.e. the dependent variables) of interest: flexural modulus, flexural strength, 
and relative flexural toughness. In total, five independent variables were chosen, including fiber 
type ratio (SF:PLLA vol% ratio), matrix type, matrix amount, and HA amount, as well as a blocking 
variable, which was the mold cavity.  
For each of these variables, a “low” and a “high” value was chosen to use in the DOE. The 
SF:PLLA ratio was either 1:9 or 9:1, as these ratios allowed for the minimum of one full layer for 
each fiber type in the final composite bar (i.e. one layer of SF fibers for the 1:9 ratio and one layer 
of PLLA fibers for the 9:1 ratio). Matrix type, a categorical variable, was either PCL or PLA, test 
how matrix type affected the bending properties of the composite. Preliminary testing showed less 
than 2 wt/vol% matrix (PCL or PLA) in the dip coating suspension did not wet fibers sufficiently, 
and more than 10 wt/vol% matrix in the dip-coating suspension caused complications in pro-
cessing the composite. So these values were chosen as the limits in the DOE. Similarly, prelimi-
nary tests showed that having greater than 15 wt/vol% HA in the dip-coating suspension caused 
complications in processing, as well as severe aggregation of HA in the final composite. As such, 
the HA amount for the DOE was either 0 wt/vol% or 15 wt/vol% in the dip-coating suspension. 
Lastly, the mold cavities were simply labeled A or B and were used to confirm that the mold cavity 
would not affect the properties of the composite samples (i.e. the samples should have the same 
properties regardless of which mold cavity they are pressed in). 
To minimize the number of runs required to complete the DOE, an assumption was made 
that there would be negligible-to-zero three-way interactions of the factors on the three dependent 
variables of interest. As such, the number of runs was reduced from 2n to 2n-1, where n is the 
number of independent variables (5), for a total of 16 runs for the DOE. The run list and sample 
compositions are listed in Table 3.1, however the runs were completed in a randomized order to 
control for error. DOE analysis was performed using DOE analytics tools in the statistical analysis 
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software Statistica. Factors were said to have a significant effect on the dependent variables if 
the p value was ≤ 0.05. Factors were said to still affect the dependent variable if the p value was 
between 0.05 and 0.20, but no definitive conclusions can be directly drawn since these p values 
were relatively high (i.e. above 0.05) [121]. As such, factors with these p values warrant further 
investigation with refined variables and experimental design. Initial analysis of effects showed 
three factors (one factor for each dependent variable) had p values that were nearly 1. As such, 
and as is common when performing DOE analysis, if a factor was deemed to have negligible 
effects on the dependent variable (i.e. it had a p value close to 1), it was rolled into error, as 
indicated by the dashes in 
Table 3.2. By rolling these factors into error, the analyses for the remaining effects are 
more discriminating (i.e. the DOE analysis will provide more accurate results for the remaining 
factors). 
Table 3.1: A list of the compositions that were made and tested for DOE in this study.   Note, the order of 
the samples was randomized to further reduce outside factors.  
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Table 3.2: The factors that have an effect on the dependent variables of interest, where the bolded num-
bers represent factors that influenced the dependent variable and blank spaces indicate that particular 
factor had virtually zero effect on the results. 
 
 
3.2.3.1. COMPOSITE PROCESSING AND FABRICATION 
The general procedure for the composite processing is shown in Figure 1.1, but it is im-
portant to note that this figure does not explicitly contain every step of the composite processing 
as it will be explained in greater detail in writing. To start, PLLA fibers were run through a dip-
coating solution of 2 wt/vol% PCL in MEK, as 2 wt/vol% was shown to have sufficient fiber wetting 
in the previous study. [56] The PLLA fibers were then run through the pultrusion die, dried, and 
this process was repeated a second time before the fibers were consolidated on a steel frame for 
the compression molding step. Next, SF fibers were coated in a similar fashion with a dip-coating 
suspension containing either PCL or PLA in DCM with and without HA (using the concentrations 
previously described) depending on the run number as shown in Table 3.1. After the second 
coating, the SF fibers were wrapped around the previously coated PLLA fibers on the metal frame, 
 45 
with the SF:PLLA fiber ratio being determined by the number of wraps of the respective fibers 
around the metal frame. As shown in Figure 3.1, the steel frame contained slots for the consoli-
dated fibers that were the same width as the slots in the compression mold. As such, once the 
fibers were consolidated on the steel frame, the frame was placed around the mold so the fibers 
lined up with the mold slots. When the fibers were properly placed in the slots, the consolidated 
fibers were then pressed at 160 °C and 200 MPa. The pressing temperature was chosen based 
on the melting temperatures of the thermoplastics used in this experiment. PCL, PLA, and PLLA 
have melting temperatures of ~60 °C [122], 150-160 °C [123], and ~170 °C [124], respectively. 
As such, using a pressing temperature of 160 °C ensures the matrix polymers (PCL and PLA) will 
melt and wet the reinforcement fibers, while the PLLA fibers remain largely unharmed. The re-
sulting composite bars were then tested via three-point bending to determine the flexural mechan-
ical properties.  
 
Figure 3.1: A schematic of the overall processing techniques used to fabricate the composites for this 
study. Note that the dip-coating suspension changes between HA/PCL/MEK and HA/PLA/DCM depending 
on which formulation is being made for the DOE. 
 
3.2.4. HA CONTENT OPTIMIZATION 
Due to the HA parameters set for the DOE, the results for effect of HA on the properties 
of the composite could not be determined with the DOE. As will be discussed in greater detail in 
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the results section, the addition of HA should have caused the modulus and strength to increase 
in such a composite as a ceramic reinforcement phase has a significantly higher modulus and 
strength comparing to the polymeric matrix. However, results from the DOE showed the contrary; 
HA had either negligible or detrimental effects on the mechanical properties of the composites. 
As such, a second study was carried out in order to optimize the HA content within the composite. 
The processing remained largely the same as previously described for the DOE, however PLLA 
fibers were omitted, focusing solely on monolithic SF/PLA/HA composites based on the DOE 
results. Briefly, SF fibers were dip-coated in a suspension containing five different concentrations 
of HA suspended in a solution of PLA dissolved in DCM, including 3, 6, 9, 12, and 15 wt/vol%. 
The five different amounts of HA were also compared to a control composite containing no HA. It 
is worth noting that the PLA content in the dip-coating suspension for this portion of the study 
remained constant at 6 wt/vol%, picking a concentration directly in the middle of the “low” and 
“high” values from the previous DOE. Following the fabrication, the composites underwent flexural 
testing using the same procedures outlined previously, and the flexural modulus and strength for 
each composition were plotted against the HA vol% for each composition. Also, the flexural tough-
ness was determined using the same method as previously described for the DOE, and the results 
were also plotted against HA content. 
3.2.4.1. CHARACTERIZATION 
The tensile properties of the SF fibers were compared by performing single fibril tensile 
tests, as described with the PLLA fibers in the previous section. First, the average diameter was 
calculated by taking measurements of 50 fibrils using FESEM imaging. The ends of single fibrils 
were then clamped between two pieces of paper and mounted in the tensile testing fixture, where 
the paper was present to ensure the fibers did not fail at the site of the clamps. Using a force ramp 
rate of 0.01 N/min, stress versus strain data was collected, and the tensile modulus and strength 
was determined. 
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Flexural tests were performed on an Instron 1011 with a three-point bending fixture. The 
tests were performed with a support span of 45 mm and at a loading rate of 20 mm/min, which 
were determined based on ASTM standard D7264. From the load and displacement data ob-
tained, flexural stress versus strain data were plotted where the flexural modulus was taken as 
the linear region of this plot. The flexural strength was taken as the maximum stress value ob-
tained during the test, and the toughness was calculated as the area under the stress versus 
strain curve up to 80% of the maximum stress after the sample yielded. 
Thermogravimetric analysis was carried out on a TA instruments Q500 machine to deter-
mine the HA wt% for different compositions prepared for this study. To ensure a homogenous 
distribution of HA within the samples, two pieces from two samples of each composition were 
tested with TGA for a total sample size n of 4. The procedure for TGA involves heating each 
sample to 800 °C at a rate of 15 °C/min, causing the PLA and SF to burn off and proving the wt% 
of HA within each sample. The wt% provided by the TGA were then converted to vol% using the 
following density values for HA, SF, and PLA, respectively:  3.156 g/cm3 [125], 1.40 g/cm3 [126], 
and 1.290 g/cm3 [127]. Since each composition has the same amount of SF and the amount of 
HA for each composition is determined through TGA, the volume percent of each component was 
calculated using the previously mentioned densities for each component in tandem with the phys-
ical dimensions of the composite bars. 
Field emission scanning electron microscopy (FESEM) was performed on the individual 
SF and PLLA fibrils as well as on composite samples using an FEI Teneo LVSEM. The average 
diameter of each fibril type was determined by size analysis on 50 fibrils for each type using 
ImageJ. Samples for transverse cross-sectional images were prepared by lowering a razor blade 
mounted in a milling machine unto the sample to obtain a clean cross section. Samples for longi-
tudinal cross sectional images were prepared by mounting composite samples in epoxy and pol-
ishing the surface using sand paper and eventually polishing with a suspension containing 5 µm 
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sized gold particles. Since the samples are nonconductive they were coated with gold palladium 
(SEM coating unit E5100, Polaron Instruments Inc.) prior to imaging, and were imaged at an 
accelerating voltage of 5 kV. The hydroxyapatite nanoparticles produced for this study were im-
aged using the FEI Tecnai T12 scanning transmission electron microscope (STEM). Fourier trans-
form infrared spectroscopy (FTIR) was utilized to prove the efficacy of the surface treatment of 
HA with CTAB. 
3.2.5. STATISTICAL ANALYSIS 
Results from the three-point bending tests were statistically analyzed using two-way anal-
ysis of variance (ANOVA) and expressed as mean ± standard deviation. Statistical significance 
was defined as p < 0.05.  
3.3. RESULTS 
3.3.1. MATERIALS 
Figure 3.2 shows FESEM images of SF and PLLA fibrils. From these images, it is apparent 
that SF has a slightly irregular shape as it is a natural fiber, and it has an average diameter of 
10.5 ± 0.65 µm. Conversely, the PLLA fibers display a perfectly cylindrical shape with an average 
diameter of 17 ± 0.69 µm. Figure 3.3 shows sample stress versus strain curves for single fibril 
tensile tests of each fiber type. The tensile tests reveal that the SF fibers have an average tensile 
modulus of 19.1 GPa and an average tensile strength of 735 MPa. By comparison, the PLLA 
fibrils have an average modulus and strength of 8.1 GPa and 392 MPa, respectively [128]. Figure 
3.4 shows the TEM images and FTIR spectroscopy performed on the HA nanoparticles. The TEM 
image shows the rod-shaped nanoparticles with an aspect ratio of ∼6. The FTIR spectra confirms 
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that HA was produced and successfully surface treated with CTAB based on the presence of 
peaks at 2850 cm-1 and 2950 cm-1 corresponding to C–H bonds that are present in CTAB. 
 
Figure 3.2: Individual fibrils of the silk fibroin (a) and poly -l-lactic acid (b) reinforcement fibers.  
 
 
Figure 3.3: Sample stress vs. strain curves for PLLA and SF fibers, showing the high stiffness and strength 
of SF and the high ductility of PLLA. 
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Figure 3.4: FTIR spectra showing the presence of CTAB on the surface of the HA nanoparticles (a) and a 
TEM image of the HA nanoparticles used for the particle reinforcement phase for this study (b).  
 
3.3.2. DESIGN OF EXPERIMENTS 
As previously mentioned, the DOE employed in this study was utilized to observe the 
effects of multiple factors in the process of making the composite materials outlined above at the 
same time, including two-way interactions between the factors.  
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Table 3.2 shows the p values of different factors and two-way interactions had on the three 
dependent variables, where bolded numbers represent factors that had an effect on the respective 
dependent variable. Also, the values shown in  
Table 3.2 represent the p values after negligible factors were removed from the model, 
which are indicated by the blank spaces in the table. After ignoring the negligible factors for the 
respective dependent variables, the p values for the remaining factors further decreased, indicat-
ing a slightly more accurate DOE model for this particle system. Figure 3.5 shows factors that 
have a significant effect on the flexural modulus of the composite material. From Figure 3.5a and 
Figure 3.5b, respectively, increased SF fiber content caused an increase in flexural modulus rel-
ative to PLLA fibers and the flexural modulus slightly decreased when HA was added to the sys-
tem. Figure 3.5c shows the two-way interaction between matrix type and matrix amount, where 
the flexural modulus decreased when adding more PCL to the system, but increased when adding 
more PLA to the system.   
 
Figure 3.5: The effect of long fiber reinforcement type (a), effect of HA amount (b), and effect of the two -
way interaction of matrix type and amount (c) on flexural modulus.  
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Figure 3.6 shows the effects four of the factors and one two-way interaction had on the 
flexural strength of the composite. Figure 3.6a-d, respectively, show that the use of more SF fibers 
over PLLA fibers increases the strength, the use of PLA as the matrix polymer increases the 
strength versus when PCL is used, increasing matrix content increases the strength, and the 
addition of HA causes the flexural strength to decrease. However, Figure 3.6e displays the effect 
of the two-way interaction between matrix amount and HA amount, showing a negligible effect 
when HA is absent from the system and matrix content is increased, but showing a significant 
increase in strength when HA is present and matrix content is increased. 
 
Figure 3.6: The effect of long-fiber reinforcement type (a), matrix type (b), matrix amount (c), HA amount 
(d), and the two-way interaction of matrix amount and HA amount (e) on flexural strength.  
 
Figure 3.7a-c shows the effects three factors, namely fiber type, matrix type and matrix 
amount, had on the toughness of the composites, while Figure 3.7d-f show the effect two-way 
interactions had on the toughness of the composite. Contrary to the effects on flexural modulus 
and strength, the use of PLLA fibers was shown to cause superior toughness over the use of SF 
fibers. Also, using PLA as the matrix increased the toughness over using PCL, and increasing the 
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matrix amount increased the toughness. Figure 3.7d shows that the addition of HA increased the 
toughness when SF fibers were used as the reinforcement, but had little effect when PLLA was 
the predominant reinforcement. Figure 3.7e shows that the addition of HA caused a decrease in 
toughness when PCL was used as the matrix polymer, however, adding HA to the system in-
creased the toughness when PLA was used as the matrix polymer. Figure 3.7f shows that the 
addition of HA increased toughness of the composite when more matrix polymer is present, but 
HA was detrimental for toughness when there was a small amount of matrix polymer present. 
 
Figure 3.7: The effect of long-fiber reinforcement type (a), matrix type (b), matrix amount (c), HA amount 
(d), and the two-way interactions of HA amount and fiber type (d), HA amount and matrix type (e), and HA 
amount and matrix amount (f) on the toughness of the composite samples.  
 
Figure 3.8 shows how well the experimental results match up with the DOE model, giving 
a predicted values versus observed values chart for each modulus, strength, and toughness in-
vestigated in this study. Also, supplemental Figure 3.9 shows the residual values (error) versus 
case number for modulus, strength, and toughness, demonstrating that the error was consistent 
throughout the entire study, leading us to believe there were negligible outside influences on the 
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outcome of the study and the factors analyzed in this DOE were the main contributors to the 
values of the dependent variables. 
 
Figure 3.8: Observed versus predicted values according to the DOE model analyzing the effect of previ-
ously mentioned factors on bending modulus (a), strength (b), and toughness (c).  
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Figure 3.9: Shows the error present on each run of the DOE for bending modulus (a), strength (b), and 
toughness (c), showing consistent error throughout the study (i.e. error present was random and not in-
fluenced by controllable outside forces). 
 
3.3.3. HA OPTIMIZATION 
Figure 3.10a shows the effect of HA content on flexural modulus and strength. As seen in 
the figure, the addition of HA exhibits an immediate impact on flexural strength, showing a statis-
tically significant increase when HA is added to the system. However, the addition of HA initially 
shows no significant effect in flexural modulus. For both flexural strength and modulus, the peak 
values were 437.0 MPa and 13.7 GPa, respectively, with no significant difference between sam-
ples with 11 vol% HA versus 16 vol%. The modulus and strength were both shown to decrease 
when the HA content exceeded 16 vol% in the sample. Similarly, the addition of HA to the com-
posite samples caused a significant increase in the flexural toughness of the composite material, 
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as seen in Figure 3.10b. The maximum toughness occurs when 16 vol% HA is used in the dip-
coating suspension with a value of 18.7 × 104 J∙m-3, with a sharp decrease occurring when the 
HA exceeds this value. The summary of the results from this study is seen in Table 3.3, where 
the optimal composition, based on flexural modulus, strength, and toughness, is indicated by the 
bolded row. Furthermore, Figure 3.11 shows sample stress vs. strain curves for the control sam-
ple (0 vol% HA), the optimal sample (16 vol% HA), and sample with the highest amount of HA in 
the composite (24 vol%) up to 80% strength retention after failure. As shown in the figure, the 
toughness and strength of the composites is significantly higher when 16 vol% HA is present 
versus when no HA and excess HA is present in the composite. Also, as will be discussed later, 
Figure 3.11 shows the delamination mode of failure most samples suffered from. Lastly, the lon-
gitudinal and transverse structure of a composite with this optimal formulation is shown in Figure 
3.12a and Figure 3.12b, respectively. From the figures, it is apparent that the SF fibers are largely 
oriented in the x direction, and the reinforcement is distributed evenly throughout. 
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Figure 3.10: A plot of flexural modulus and strength (a) and flexural toughness (b) of the SF/HA reinforced 
PLA composites with respect to HA vol% within the composite.  
 
Table 3.3: Summary of the results from the 3-point bending tests, showing the effect of HA vol% within 
the composite on flexural modulus, strength, and toughness.  The optimal composition in this study con-
tained 16 vol% HA, indicated in the table by the bolded numbers.  
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Figure 3.11: Stress vs. strain curves for composite samples with 0, 16, and 24 vol% HA, where the samples 
with 0 and 24 vol% HA show delamination with negligible plastic deformation and the sample with 16 vol% 
HA exhibits plastic deformation and significantly higher strength and toughness compared to other formu-
lations of the composite. 
 
 
Figure 3.12: FESEM images showing the transverse (a) and longitudinal (b) cross sections of a composite 
sample containing 16 vol% HA. 
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3.3.4. DISCUSSION 
The elastic modulus for degummed SF used in this study was calculated to be 19.1 GPa, 
which correlates well to the range of values found in literature of 16-22.6 GPa [56, 129]. This value 
is significantly higher than the modulus of 8.1 GPa for PLLA fibers, as calculated by Heimbach et 
al. [56] As such, the DOE showed that samples made with predominantly SF fibers, rather than 
PLLA fibers, had significantly higher flexural moduli compared to samples made with predomi-
nantly PLLA fibers as expected. [130] However, the addition of HA had the unexpected conse-
quence of slightly decreasing the flexural modulus, which is likely due to the nature of this partic-
ular DOE. The amount of HA used in the DOE was chosen to be 15 wt/vol% in the dip-coating 
suspension, and high concentrations of nanoparticles causes the HA to agglomerate and de-
crease mechanical properties of composite materials. [131, 132] This unexpected result of HA 
decreasing the modulus was the driving force for performing the latter study relating flexural prop-
erties of SF/HA-reinforced composites to HA content, which will be discussed in further detail later. 
Another unexpected result of the DOE was the inconsistent effects PLA and PCL had on the 
modulus of the composite. According to rule of mixtures, and assuming proper fiber wetting, it is 
expected that increasing the matrix content in the composite will decrease the modulus as the 
matrix has a relatively lower modulus comparing to that of the fibers. [130] However, as previously 
mentioned, while increasing PCL provided this expected result, increasing the PLA content 
caused a slight increase in modulus. This inconsistency can be explained by the differences in 
viscosity of the two matrix polymers, where the PCL has a much higher viscosity than the PLA.  
At the “low” amounts of matrix for the DOE, it is likely there was not enough matrix to properly wet 
the fibers, especially when HA was present in the system. As such, when PLA content was in-
creased (i.e. to the “high” value of the DOE), the matrix could more sufficiently wet the fibers, 
while the pressing step will expel a lot of the excess matrix, thus increasing the modulus over the 
“low” amount. However, due to the drastic increase in viscosity over PLA, when the PCL content 
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is increased, excess matrix material is less likely to be removed from the system, thus causing a 
decrease in modulus, as expected based on the rule of mixtures. 
As expected, samples prepared with SF as the long fiber reinforcement had higher flexural 
strength values than those prepared with PLLA because SF is shown in literature as having a 
much higher tensile strength. [129, 130, 133] Similarly, the use of PLA as the matrix material 
proved to produce samples with higher strength values over those made with PCL due to the high 
strength of PLA relative to PCL (i.e. PLA and PCL have reported tensile strengths of 32.5 MPa 
and 10.5 MPa, respectively). [133, 134] The DOE also revealed that increasing the matrix content 
improved the strength of the composite, which is due to increased fiber wetting and a subsequent 
increase in interfacial shear strength within the composite. [135] Similar to the effect HA had on 
the flexural modulus in this DOE, the addition of HA had a detrimental effect on the flexural 
strength due to the formation of aggregated HA particles, which has been shown to be severely 
damaging to mechanical properties of composites. [132] Figure 3.6e shows the two-way interac-
tion between HA amount and matrix amount. This figure shows that when there is a small amount 
of matrix polymer present the addition of HA is significantly detrimental to the strength of the 
composite. However, when HA is present with a high amount of matrix polymer the strength in-
creases to a statistically equal value relative to when HA is not present in the composite, which is 
likely due to superior wetting of the fibers and particles when more matrix is present with HA. [135] 
Toughness of the composites suffered greatly when SF fibers were the predominant fibers 
in the sample because of the tendency for the samples to undergo Mode II delamination, a phe-
nomenon not seen in samples made with PLLA. [136] The apparent increase in toughness when 
using PLA as the matrix is a result of the increased strength. [137] Due to the delamination of the 
samples with SF reinforcement, there was little plastic deformation. As such, the increased 
strength when using a PLA matrix resulted in an increased toughness as the PLA simply post-
poned the mode II delamination of the sample compared to samples with a PCL matrix. [138] As 
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seen previously with the effect of matrix amount on strength, increased matrix content resulted in 
tougher composite materials, likely due to increased wetting of the fibers and particles. [135] Fig-
ure 3.7d displays the two-way interaction between long fiber reinforcement type and HA amount, 
showing the addition of HA when SF is the primary reinforcement material increases toughness 
while it has a negligible effect when PLLA is the predominant reinforcement material due to the 
inherently great toughness of the PLLA fibers used. The presence of HA particles enable crack 
deflection to occur within the composite, which is shown in literature to increase the toughness 
within composites. [139] The effect of HA amount and matrix type on toughness is another two-
way interaction present in the study. The DOE showed that the presence of HA when using PLA 
as the matrix increased the toughness of the composite, but when using PCL as the matrix ma-
terial the toughness showed a slight decrease. This is likely caused by the drastic increase in 
matrix viscosity when particle reinforcement is present in a polymer matrix, which is known to 
hinder fiber wetting within composites, as well as the previously mentioned agglomeration issue 
present with such a high HA content. [140, 141] Due to the significantly higher viscosity of PCL, 
the addition of HA makes it even more difficult to properly wet the fibers and particles. Figure 3.7f 
shows the same relationship as Figure 3.6e, where the addition of HA increases toughness when 
there is a high amount of matrix present, but the addition of HA is detrimental when there is a low 
amount of matrix. This is due to the aforementioned fiber/particle wetting issue when using low 
amounts of matrix, which was the driving force for the need to perform a study to optimize the HA 
content within the composite. [135] 
Figure 3.10a shows the relationship between the flexural modulus and strength and HA 
content.  From the figure, when 6 vol% HA is present in the composite, there is negligible effect 
on the modulus relative to samples with no HA.  However, when the composites contained 11 
vol% and 16 vol% HA the flexural modulus increased to 13.65 GPa and 13.7 GPa, respectively, 
both of which are higher than values found in literature for bioresorbable bone fixation composites.  
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When the HA exceeds these values, the flexural modulus decreases significantly due to a com-
bined effect of HA agglomeration and poor particle wetting by the matrix polymer. [132, 142] When 
examining flexural strength, the strength significantly increases from 207 MPa to 344 MPa when 
HA content increased from 0 to 6 vol%.  The strength further increases to 424 MPa and 437 MPa 
when 11 vol% and 16 vol% are present, respectively.  Upon further increasing the HA content to 
20 and 24 vol%, the strength of the composites decreases to 367 MPa and 355 MPa, respectively.  
Following a similar trend, HA is shown to improve the toughness of the composite samples during 
bending, as seen in Figure 3.10b.  The addition of HA immediately improves the toughness of the 
composite due to greatly improved crack deflection within the matrix, reaching a peak value of 
18.7×104 J∙m-3 when there is 16 vol% HA in the composite. [143] Drummond et al. [143] also 
notes that while particle reinforcement significantly improves toughness due to crack deflection, 
particle agglomerates act more as stress concentrations than crack deflectors, which is the reason 
for the significant decrease in toughness beyond an HA content of 16 vol%.  It is also important 
to note that while composites with 16 vol% HA were optimal for the present study, the mechanical 
properties could be improved further by adjusting the long fiber and matrix content as well.  
Another important note is that while appropriate moduli and strengths were achieved, all 
of the samples except for the samples of optimal formulation failed due to mode II delamination 
[136], as discussed previously. While this remained true for many of the samples with 16 vol% 
HA in the composite as well, some plastic deformation was seen in these samples prior to delam-
ination. [144] This is shown in Figure 3.11, where the 0 vol% HA and 24 vol% HA stress vs. strain 
curves show delamination before any notable plastic deformation, whereas the sample with the 
optimal formulation showed plastic deformation, which is the reason or such a large increase in 
toughness. Furthermore, the failure of the 16 vol% HA sample more closely resembles that of 
natural bone. [145] 
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Improvements can be made to this composite by targeting the shortcomings pointed out 
in this study.  The HA used in the present study is polycrystalline HA with an aspect ratio of 6. [56] 
However, if HA particles were prepared to be single crystal and have a higher aspect ratio, the 
particles would have a significantly higher modulus and be more effective at transferring the load 
within the composite.[26-28] Further improvements could be achieved by reducing HA aggrega-
tion within the composite. This could be done by increasing the matrix amount in the dip-coating 
suspension (i.e. increasing the viscosity of the suspension), which has been shown to decrease 
particle agglomeration and would preserve the matrix-to-reinforcement ratio required to make ef-
fective composites at high particle loadings. [146] 
3.3.5. CONCLUSIONS 
This study showed the development of a load-bearing composite that is bioresorbable 
using silk fibroin as the primary reinforcement material.  A DOE was performed to determine the 
effects various factors had on the flexural modulus, strength, and toughness of the composites.  
In particular, this DOE analyzed how different long fiber reinforcement materials, matrix types, 
matrix amount, and HA amounts affected the three mechanical properties of interest.  From the 
data obtained performing the DOE, a subsequent study was performed to optimize the HA particle 
reinforcement content for composites containing SF fibers and PLA matrix.  Using SF, PLA, and 
HA, which are all currently FDA approved materials, high performance composites were fabri-
cated that achieved a flexural modulus, strength, and toughness of 13.7 GPa, 437 MPa, and 18.7 
× 104 J∙m-3, respectively, where the modulus is in the range of the highest reported values for a 
bioresorbable composite for bone fixation and the strength far exceeds the requirements for such 
a device.  FESEM images show the reinforcement fibers are aligned in the x direction, allowing 
the high stiffness and strength to be achieved.  Such a composite material shows promise for use 
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as a load-bearing material for fixation devices, providing a better long-term solution over the metal 
alternatives currently in place. 
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CHAPTER 4: IN VITRO BEHAVIOR OF SILK FIBROIN-BASED 
COMPOSITE RESORBABLE BONE FIXATION DEVICES 
4.1. INTRODUCTION 
Due to the lack of materials that possess the mechanical properties and biodegradability 
desired for bone fixation plates, composites have been extensively researched. These compo-
sites are typically composed of PLA or PLGA reinforced with a bioceramic [32], with perhaps the 
most successful attempt thus far coming from Shikinami et al. [147]. Using hydroxyapatite-rein-
forced poly-L-lactic acid (PLLA) combined with novel compression molding techniques that ena-
bled better alignment of the PLLA chains within the composite, they were able to achieve a mod-
ulus of 12.1 GPa but were functionally limited to a material with a modulus of 9.7 GPa. While this 
represents a vast improvement over commercially available resorbable fixation devices, the me-
chanical properties limit the device’s usage to mandible fractures, which is considered to be a 
bone that undergoes moderate loading [148]. Further work involving composite fixation devices 
involved the fabrication of a three-phase composite consisting of degummed silk fibroin fibers, 
hydroxyapatite nanorods, and PLA. Heimbach et al. reported fabricating a material that had a 
modulus of 13.7 GPa and a strength of 435 MPa [59]. Despite having sufficient strength, the 
composite still lacked adequate stiffness for load-bearing applications and suffered from mode II 
delamination [149], rendering the material useless after yielding.  
Improving upon previous work [128, 59, 150], this section seeks to fabricate a composite 
material that will have a modulus matching the upper range of natural bone, a strength that is at 
least as high as natural bone, and the ability to degrade in vivo safely. Furthermore, this paper 
seeks to outline processing steps needed to fabricate functional fixation devices comprised of this 
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three-phase composite. As such, the in vitro degradation and in vitro cell viability properties will 
be analyzed to ensure the biocompatibility of the composite for future in vivo studies. 
4.2. MATERIALS AND METHODS 
4.2.1. MATERIALS 
 Sodium phosphate monobasic anhydrous (NaH2PO4, 99%, for analysis), calcium 
nitrate tetrahydrate (Ca(NO3)2∙4H2O, certified ACS), gelatin type A (laboratory grade), urea (cer-
tified ACS), acetic acid (CH3COOH, glacial, certified ACS), dichloromethane (DCM, 99.8+%, for 
analysis, stabilized with amylene), and Invitrogen ReadyProbe blue/green cell viability imaging kit 
were all purchased from Fisher Scientific. The enzyme protease XIV (≥ 3.5 U/mg) was purchased 
from Sigma-Aldrich. Teleflex Medical Inc generously supplied silk fibroin (SF) fibers and polylactic 
acid (PLA).    
4.2.2. HYDROXYAPATITE SYNTHESIS 
Hydroxyapatite reinforcement nanowhiskers were prepared based on a modified protocol 
involving urea decomposition seen elsewhere in the literature [151]. To start, an aqueous solution 
was made by combining Ca(NO3)2∙4H2O (0.06 mol/L), NaH2PO4 (0.06 mol/L), gelatin (1.2 g/L), 
and urea (0.12 mol/L) in deionized water (DiW) at room temperature. Once the reagents were 
completely dissolved, the contents were poured into a boiling flask, and the entire mixture was 
heated to 95 °C for 96 h. The HA nanowhiskers were then washed with DiW three times to remove 
the ammonia that results from the decomposition of urea [152]. The synthesized HA whiskers 
have a thin layer of gelatin on their surface [151], which is essential for the particles to grow 
preferentially along the longitudinal axis, yielding a high aspect ratio. However, the presence of 
gelatin on the particles’ surface increases particle agglomeration and can be detrimental to the 
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bonding between the HA particles and PLA matrix in the final composite. For this reason, after 
being rinsed with DiW, the HA particles were stirred in a 0.5 M solution of acetic acid overnight, 
which is a concentration that is known to dissolve gelatin but leave HA unscathed [153]. The HA 
was then washed three more times with DiW and dried for future use.  
4.2.3. COMPOSITE FABRICATION 
The fiber- and nanowhisker-reinforced composites were fabricated using unique pro-
cessing methods described in previous publications [128, 59, 150]. Briefly, and as outlined in 
Figure 4.1, raw, degummed silk fibroin fibers were dip-coated in a suspension consisting of 8.5 
wt/vol% HA and 5 wt/vol% PLA in DCM, concentrations that were selected based on previous 
work [59]. The fiber bundle was pulled through a pultrusion die to flatten the bundle into a ribbon 
shape and help wet the fibers with the matrix polymer. The coated fibers were then dried in a 
vacuum desiccator, and the ribbon was then dip-coated and run through the pultrusion die one 
more time to help accumulate more matrix on the fibers. For the second pultrusion step, thin 
spacers (i.e. razor blades) were placed between the two parts of the die to allow for greater matrix 
accumulation (without the spacers the second dip-coating would be negated by the matrix being 
scraped off in the pultrusion die). After the second dip-coating and pultrusion steps the SF fibers 
were consolidated on a metal frame by wrapping the fibers around the frame. This consolidation 
step keeps the fibers in slight tension, thus providing greater fiber alignment in the x-axis in the 
final composite. To ensure all of the DCM was vacated from the fibers, the consolidated fibers 
were vacuum-dried overnight prior to the compression molding step. 
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Figure 4.1: The overall processing steps utilized to fabricate the three -phase composites analyzed in this 
study, showing the dip-coating (a), pultrusion (b), and compression molding step  (c). 
 
For the compression molding step, two custom molds were fabricated, as shown in Figure 
4.2a and Figure 4.2b. The first mold results in rectangular composite bars with a length and width 
of 55 mm and 12.7 mm, respectively. These rectangular bars were used to obtain flexural modulus 
values for the composites, which allows for a direct comparison to the modulus of natural bone 
and other fixation device materials. The second mold was designed based on currently used metal 
devices [154], which have a curvature so they contour to the bone. The radius of curvature of a 
sample metal fixation device was measured using a Gage Master GMX optical comparator. From 
this, a radius of curvature of 12.7 mm was incorporated into the compression mold design. The 
length and width of the slots in the mold were 60 mm and 10 mm, respectively, the latter of which 
was also based on current metal designs. When making the rectangular bars, the coated SF fibers 
were wrapped around the consolidation frame 125 times, and when making the curved bars, the 
coated SF fibers were wrapped around the consolidation frame 75 times. Before placing the con-
solidated fibers in the compression molds, the mold slots were sprayed with a demolding spray 
(WD-40 Specialist Dry Lube PTFE Spray) to guarantee the samples would not stick to the sur-
faces of the mold. The mold was then placed in a Carver press and heated to 170 °C prior to 
pressing the samples. The samples were pressed with a pressure up to 200 MPa, increasing by 
increments of 40 MPa. The pressure was held for 2 minutes at each increment, held for 15 
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minutes at 200 MPa, finally the mold was cooled to room temperature. The frame was cut from 
the mold and then the mold was clamped down, and a hammer and chisel were used to shear 
the frayed ends of the composites off, leaving just dense, nonporous SF/HA/PLA composites. 
This was the final step of sample preparation for the rectangular composites, but to make the 
curved composites more realistic with respect to metal devices, holes were drilled into them. Spe-
cial care was taken to drill clean holes. Following similar methods used to drill holes in carbon 
fiber laminates [155], a brad-point drill bit was used to drill the holes. The composite sample was 
then placed in a wooden mold to avoid fiber pushout, mounted in a drill press, and drilled slowly. 
A total of two holes were drilled in each sample, each with their center placed 10 mm from either 
end of the sample and both in the middle of the sample’s y-axis. The resulting composite bars 
then underwent further analysis.  
 
Figure 4.2: The compression mold used to make the rectangular composite bars (a) and the curved com-
posite bars (b). 
 
 
 
 70 
4.2.4. NANOWHISKER ORIENTATION 
The alignment of the HA nanowhiskers within the composites was calculated with the help 
of wide-angle X-ray scattering (WAXS). The WAXS spectra were collected at each step of the 
composite fabrication process (i.e. after the first pultrusion, second pultrusion, and finally after the 
compression molding step) using the Oxford Diffraction Xcalibur PX Ultra. Briefly, either the 
coated fiber ribbon or a pressed composite was loaded into the WAXS machine, and the WAXS 
spectra was collected for both the SF and HA. In the case of a full composite, a thin (≤ 1 mm) 
sheet was isolated to allow the X-ray beam to pass through the sample. Since the HA nanowhisk-
ers are single crystal particles and they grow preferentially along their c-axis, the [002] plane of 
HA can be used to calculate the overall alignment of the HA within the composite [44]. This dis-
tribution of alignment can be more easily understood when put in terms of the Herman’s orienta-
tion constant. The Herman’s orientation constant is presented as a range from -0.5 to 1 with 
respect to an axis of interest [156], which in this case is the x-axis of the composite, or the axis 
along the SF fibers. Using the Herman’s scale, a value of -0.5 indicates that the particles are 
perfectly aligned perpendicular to the axis of interest, 0 means the particles are randomly oriented, 
and 1 indicates that the particles are perfectly aligned with the axis of interest. The intensity of the 
[002] peak in the WAXS spectra can be plotted with respect to the azimuthal angle (the angle 
from 0° to 360° around the circular pattern of the WAXS spectra). From this plot, the Herman’s 
orientation factor was calculated using Equation 4.1 and Equation 4.2 below.  
 
Equation 4.1 
cos2y =
I y( )siny cos2y dy
0
p 2
ò
I y( )siny dy
0
p 2
ò
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Equation 4.2 
H =
1
2
3 cos2y -1( )  
 
Here, I is the intensity of the [002] peak in the WAXS spectra with respect to the azimuthal 
angle ψ, and H is the Herman’s orientation factor. After calculating the Herman’s orientation factor 
for the HA nanowhiskers, the bending modulus of the fabricated composites can be estimated 
using modified Halpin-Tsai equations that have been used previously for similar applications and 
are discussed in greater detail below. 
4.2.4.1. COMPOSITE MODULUS ESTIMATION 
The modulus of the composites in this study needed to be estimated using a two-step 
approach because of their three-phase nature. Typically, for unidirectional, long-fiber reinforced 
composites the rule of mixtures can be used to estimate the modulus [44]. Likewise, Halpin-Tsai 
equations are commonly used to predict the modulus of particle-reinforced composites [157]. As 
such, the modulus of these composites was calculated assuming the matrix is a particle-rein-
forced composite (PLA reinforced with HA nanowhiskers), and this composite matrix is part of a 
long-fiber-reinforced composite. So, first the modulus of the composite matrix was calculated, and 
then the rule of mixtures was applied to estimate the modulus of the entire composite. For this 
particular application, the Halpin-Tsai equations needed to be modified slightly to account for the 
distribution of orientation of the HA nanowhiskers, and these equations are shown below.   
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Equation 4.4 
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E
T
= E
PLA
1+x
T
E
11
E
PLA
-1
E
11
E
PLA
+x
T
æ
è
ç
ç
ç
ç
ö
ø
÷
÷
÷
÷
j
HA
1-
E
11
E
PLA
-1
E
11
E
PLA
+x
T
æ
è
ç
ç
ç
ç
ö
ø
÷
÷
÷
÷
j
HA
 
 
Equation 4.6 
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Equation 4.7 
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Equation 4.8 
x
LT
=1+ 40j
HA  
 
In these equations, EPLA is the Young’s modulus of PLA (1.4 GPa), E33 longitudinal mod-
ulus of HA (140 GPa), E11 is the transverse modulus of HA (110 GPa), GT is the shear modulus 
of HA (40 GPa), GPLA is the shear modulus of PLA (1.3 GPa), φHA is the volume fraction of HA 
within the matrix (0.38), EL is the longitudinal modulus of the composite matrix, ET is the transverse 
modulus of the matrix, GLT is the shear modulus of matrix, ξ is the reinforcement efficiency of the 
respective modulus being calculated, and AR is the aspect ratio of the nanowhiskers (31.5).  
The former equations are used to calculate the moduli of the matrix under the assumption 
that the nanowhiskers are randomly oriented. To calculate the elastic modulus of the matrix in the 
direction of the long fiber reinforcement, the following equations are used: 
 
Equation 4.9 
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Equation 4.10 
E =
ò I q( )E q( )dq
ò I q( )dq  
 
Here, E(θ) is the modulus of the matrix when the HA nanowhiskers are aligned with a 
certain misalignment angle θ, ν12 is the Poisson’s ratio of PLA (0.36), I(θ) is the misalignment 
distribution of HA nanowhiskers (the intensity versus azimuthal angle plot obtained from the 
WAXS spectra), and E  is the modulus of the matrix in the direction of the silk fibroin fiber rein-
forcement.  
Due to the nearly perfect alignment of the silk fibroin fibers, once the value of E  is calcu-
lated, the rule of mixtures can be applied to calculate the modulus of the final composite. Such an 
equation would look like the following: 
Equation 4.11 
E
composite
= E
SF
´j
SF
+ E
matrix
´j
matrix  
 
Where Ecomposite is the modulus of the total composite, ESF is the modulus of silk fibroin 
(19.1 GPa), φSF is the volume fraction of the silk fibroin (0.51), Ematrix is the same as E  from above 
(calculated to be 27.2 GPa), φmatrix is the volume fraction of the composite matrix (0.49). 
4.2.5. IN VITRO DEGRADATION 
It has been shown in the literature that silk does not degrade hydrolytically in vitro [58], 
but rather an enzyme must be used to induce degradation. Protease XIV was chosen as the 
degradation enzyme as it is the most commonly used enzyme in literature with regards to in vitro 
silk fibroin degradation [158, 159]. To start, curved composite samples with drilled holes were 
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vacuum dried overnight before obtaining an initial mass. Samples were incubated in 50 mL of 
degradation media containing 5 U/mL of protease XIV [160] in phosphate buffered saline (1×PBS, 
pH = 7.4) [161]. Samples were incubated for 8 weeks, with degradation media being replaced 
every other day so the enzyme remains active [57]. The composite bars were removed from the 
media after 1, 4, and 8 weeks. The samples were then rinsed with DiW to remove loose particles, 
vacuum dried overnight, and massed a final time to record any weight loss that occurred. Lastly, 
the composite samples were tested in three-point bending to observe changes in flexural stiffness 
compared to samples that did not undergo degradation. 
4.2.6. IN VITRO CELL VIABILITY ASSAY 
4.2.6.1. CELL CULTURE 
Mouse calvarial 3T3-E1 (MC3T3-E1, ATCC CRL-2593, USA) cells were used to examine 
the in vitro cytocompatibility of the silk composites fabricated in this study. MC3T3-E1 cells were 
cultured in a flask (FALCON, USA) containing 10 mL cell culture media (CCM) consisting of α-
minimum essential media (α-MEM; Gibco, Invitrogen, Inc., USA) supplemented with 10% fetal 
bovine serum (FBS; Gibco, Invitrogen, Inc., USA) and 1% penicillin-streptomycin (Gibco, Invitro-
gen, Inc., USA). Cells were cultured and sub-passaged when reaching 80-90% confluence in 
normoxia atmosphere of 5% CO2 at 37 ℃ maintained by an incubator (NAPCO, USA). 
4.2.6.2. CELL PROLIFERATION AND ATTACHMENT 
AlamarBlue assay was used to evaluate the proliferation of cells seeded on the compo-
sites (n = 3). The composites were cut into small blocks with dimensions of ~20×10×2 mm and 
then disinfected in 75% ethanol for 2 h with the ethanol being refreshed every 30 min. The sam-
ples were then rinsed with PBS thrice for 10 min and immersed in CCM overnight to adsorb pro-
teins. The samples were then transferred to 12-well plates and seeded with 1×105 cells/well 
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MC3T3. The cells were cultured for 14 days with CCM refreshed every other day. After incubating 
for 1 day, samples that attached with cells were transferred to a new 12-well plate, leaving behind 
the cells that escaped from samples. Phenol-red-free CCM supplemented with 10% alamarBlue 
(Invitrogen, USA) was added to each well. After culturing for another 4 h, 100 μL of the culture 
solution was transferred from each well to a 96-well plate to measure the absorbance at wave-
lengths of 570 nm and 600 nm by a microplate reader (BioTek, USA). The samples were then 
rinsed with PBS twice to remove residue alamarBlue, and 2 mL of fresh CCM was added to each 
well and refreshed every other day. Cell proliferation was determined by measuring the percent 
reduction of alamarBlue calculated according to the following equation provided by the assay 
[162]: 
Equation 4.12 
 
117,216´ A
l
1 -80,586´ A
l
2
155,677´ ¢A
l
2 -14,652´ ¢A
l
1
´100%
 
 
where A is the absorbance of the test wells; A’ is the absorbance of negative control wells 
(CCM and alamarBlue without sample and cells); λ1 = 570 nm and λ2 = 600 nm. 
4.2.6.3. LIVE/DEAD CELL VIABILITY 
To evaluate the cell viability of cells seeded on the composites, a ReadyProbe Blue/Green 
Cell Viability Imaging Kit (Invitrogen, USA) was used. Briefly, MC3T3 cells were seeded on the 
composites at a density of 1 x 105 cells/well (n = 2). After an incubation of 14 days, cell-attached 
samples were rinsed against PBS twice for 10 min and then stained in CCM containing the Kit for 
30 min before imaging using Nikon A1R laser scanning confocal microscopy (LSCM). In this as-
say, the NucBlue Live reagent stains the nuclei of all cells while the NucGreen Dead regent stains 
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only the nuclei of dead cells with compromised plasma membranes [163]. To void the autofluo-
rescence from the composite, a sample without cells was also stained and imaged accordingly 
as a negative control. 
4.2.7. CHARACTERIZATION 
Fourier transform infrared spectroscopy (FTIR), X-ray powder diffraction (XRD) and field 
emission scanning electron microscopy (FESEM) were performed to characterize the HA synthe-
sized, the results will be shown in the supplemental materials section. FTIR spectra were obtained 
before and after the aforementioned acetic acid washing step to confirm the removal of the gelatin 
coating. This test was performed using the Specac Quest Diamond ATR accessory over the 
wavenumber range of 4000 to 400 cm-1. XRD spectra were acquired using the Bruker D2 Phaser 
X-ray diffractometer with a copper target, collecting data between 10 and 80 2𝜃, and was per-
formed before and after the acetic washing step to ensure the 0.5 M acetic acid rinse did not 
cause any unwanted phase changes. FESEM (Thermo Scientific VolumeScope) images were 
collected before and after washing the particles with acetic acid to confirm that the wash did not 
cause any change in morphology. Particle morphology was determined by measuring the length 
and width of 100 HA whiskers using ImageJ before and after the acetic acid treatment. 
FESEM imaging was also used to observe transverse and longitudinal cross-sections of 
the composite bars fabricated in this study. To start, composite bars were embedded in epoxy 
and subsequently ground down with sandpaper and finally polished using a 3 µm diamond sus-
pension (Leco Premium Diamond Suspension, heavy concentration). Longitudinal cross sections 
of the composite were acquired by splitting the composite bars along the x-y plane and imaging 
that surface. 
Natural bone tissue is a dynamic, constantly changing material that undergoes both tensile 
and compressive forces [164]. To accurately replicate such forces, three-point bending tests were 
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performed on both rectangular and curved samples fabricated in this study [165]. An Instron 
model 1011 was used with a three-point bending fixture that had a support span of 45 mm and a 
cross-head speed of 20 mm/min. Flexural tests were carried out until the resulting load dropped 
below 80% of the maximum load (i.e. if the maximum load of the sample was 600 N, the test was 
stopped when the load dropped below 480 N). The curved samples underwent similar testing to 
analyze how the bending stiffness changed as a function of degradation time. Bending stiffness 
is a direct measurement of how much force is needed to bend a sample a certain amount regard-
less of shape [166], and is determined by the load vs. displacement curve. The loading capacity 
of the composites was also determined and was taken to be the maximum force imparted on the 
samples during the bending tests. Also, a unique bending fixture was fabricated for testing the 
curved samples, in which the support pins and loading pin contour to the curvature of the samples 
to mimic best how the fixation device would contour to natural bone. Otherwise, the same testing 
parameters were used as previously described, where a support span of 45 mm and a crosshead 
speed of 20 mm/min were used. A sample size of n = 3 was used for each testing group.  
The weight percent (wt%) of HA within the composite samples was determined via ther-
mogravimetric analysis (TGA), using a TA Instruments Q500 TGA machine. Two small sections 
(~10-15 mg) were cut from two different spots of each sample and the pieces were heated until 
the PLA and SF burned off, leaving only HA. After determining the wt% of the HA, the vol% was 
calculated using the following densities for PLA, HA, and SF, respectively: 1.290 g/cm3 [127], 
3.156 g/cm3 [125], and 1.40 g/cm3 [126]. Since the amount of SF in the composite is known from 
the regulated number of fibers that go into each composite, and the amount of HA is determined 
via TGA, the vol% of each component can be calculated using the nominal densities of the con-
stituents and the mass and volume of the composite bars, as described previously [59]. 
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4.2.8. STATISTICAL ANALYSIS 
Results from the three-point bending and cell viability tests were statistically analyzed us-
ing a two-way analysis of variance (ANOVA) and expressed as mean ± standard deviation. Sta-
tistical significance was defined as p < 0.05.  
4.3. RESULTS 
4.3.1. HA SYNTHESIS AND CHARACTERIZATION 
The FTIR and XRD spectra are shown in Figure 4.3a and Figure 4.3b, respectively. The 
FTIR spectra show peaks that are characteristic of hydroxyapatite [167], where the peaks for the 
phosphate functional group (PO4
3−) are at 560 and 1000 cm-1, the peaks at 1500 and 3400 cm-1 
correlate to H2O, and the peak at 3500 cm-1, which is difficult to see because of the water peak, 
represents the hydroxide group (OH–). Prior to the acetic acid wash, gelatin is observed at the 
peaks seen at 2825 and 2910 cm-1 (C–H bonds) and the small peaks at 1350 cm-1 (C–N bonds). 
The absence of these peaks in the spectra taken after the acetic acid wash proves the efficacy of 
the acetic acid at removing the gelatin coating [168]. The XRD spectra in Figure 4.3b indicates 
the synthesized hydroxyapatite matches the pattern of standard HA ICDD 9-432 [169]. Both spec-
tra also reveal that no other phase is present before or after the acetic acid washing, suggesting 
that the removal of gelatin does not coincide with a phase change of HA. Maintaining the HA 
phase is crucial because aside from substituted calcium phosphates (i.e. FHA), HA has superior 
mechanical properties and more desirable degradation properties when compared with other cal-
cium phosphates [170]. The FESEM micrographs in Figure 4.4a and Figure 4.4b show that the 
acetic acid treatment does not affect the morphology of the HA nanowhiskers, and the final parti-
cles have an average length, diameter, and aspect ratio of 6.8 ± 4.0 µm, 0.22 ± 0.07 µm, and 31.5 
± 15.5, respectively. 
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Figure 4.3: The XRD (a) and the FTIR (b) spectra collected that confirm HA was the calcium phosphate 
phase synthesized for the study and that the acetic acid wash effec tively removes the gelatin coating 
without causing a phase change of HA. 
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Figure 4.4: FESEM images taken before (a) and after (b) the acetic acid wash, used to calculate the 
dimensions of the HA nanowhiskers and to confirm the acetic did not change the morphology of the HA.  
 
4.3.2. COMPOSITE CHARACTERIZATION 
4.3.2.1. MECHANICAL PROPERTIES 
As shown by the TGA results in Figure 4.5a and Figure 4.5b, the rectangular and curved 
composite samples contained an average of 30.3 ± 1.8 wt% and 30.1 ± 1.6 wt%, respectively. 
Using the calculation outlined in a previous paper [59], it was determined that this wt% correlated 
to an average volume fraction of 19.6 vol%. Figure 4.6 shows the stress vs. strain curves for the 
rectangular samples tested via three-point bending in this study. This reveals that with 19.6 vol% 
HA the composite bars achieved a flexural modulus and strength of 21.1 ± 0.45 GPa and 536 ± 
23 MPa, respectively. These curves also indicate that the samples fractured via fibrous failure, 
and no catastrophic failure was observed during the study. This apparent fibrous failure is shown 
in Figure 4.7a, where a rectangular composite bar is seen after undergoing three-point bending. 
Figure 4.7b and Figure 4.7c also show the fiber/matrix distribution and the fiber alignment within 
the composites, respectively. Figure 4.7b also shows the composites have minimal porosity, and 
no significant porosity was observed during FESEM imaging. Figure 4.8 shows a composite that 
was made using the curved compression mold designed based on the current metal devices. 
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Screw holes were drilled into the samples with minimal fiber pushout and there was no apparent 
change in composite microstructure based on TGA results and FESEM images. 
 
Figure 4.5: TGA spectra from both the rectangular (a) and curved (b) composite samples, indicating the 
change in mold design does not affect the composition of the composites. The four lines seen in each 
spectra represent four composites with the same formulation, to ensure a homogenous distribution of 
constituents within the composites. 
 
 
Figure 4.6: Three-point bending curves obtained from testing the rectangular composite samples, where 
fibrous failure is evident based on the gradual decrease in stress after the samples yield.  
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Figure 4.7: A composite sample after undergoing three-point bending tests (a) and a transverse cross 
section (b) and a longitudinal cross section (c) of a composite sample.  
 
 
Figure 4.8: A composite, curved device fabricated using the curved mold seen in Figure 4.2b, where a 
12.6 mm radius of curvature was incorporated based on the current metal devices.  
 
4.3.2.2. PARTICLE ORIENTATION 
WAXS spectra were used to determine the orientation distribution of HA nanowhiskers 
within the composite. Figure 4.9a shows a sample of what the WAXS spectra looked like for the 
samples, in which a program in the WAXS software suite measured the intensity of the [002] plane 
of the HA in the composite sample. If the particles were randomly oriented then the spectra would 
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have equal intensity at all azimuthal angles, however, the WAXS spectra obtained from the com-
posite samples fabricated here show the HA nanowhiskers align preferentially along the long SF 
fibers. Using the intensity versus azimuthal angle curve seen in Figure 4.9b in tandem with the 
equations for Herman’s orientation described previously, it was calculated that the average Her-
man’s orientation factor for HA within the composites was 0.41, indicating partial alignment. This 
same process was used to calculate the Herman’s orientation factor of the HA after each of the 
dip-coating/pultrusion steps as well. This revealed that the orientation factor after the first and 
second dip-coating steps was 0.11 and 0.06, respectively. These results are summarized in Table 
4.1 and indicate that most of the particle alignment occurs due to the compression molding step 
of the process. Using the Herman’s orientation factor calculated for HA within the final composite, 
the expected modulus of the composite was calculated using the modified Halpin-Tsai equations 
described in this paper.  
 
Figure 4.9: WAXS spectra obtained from a composite sample (a) and the resulting intensity versus azi-
muthal angle distribution (b) that allows the nanowhisker alignment to be calculated.  
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Table 4.1: A summary of the Herman’s orientation of the HA nanowhiskers, obtained from performing 
WAXS analysis on the silk fibers after one dip-coating, two dip-coatings, and on an entire composite 
sample. 
 
 
4.3.2.3. COMPOSITE MODULUS ESTIMATION 
Figure 4.10 shows the calculated moduli of SF/HA/PLA composites produced for this study 
using the modified Halpin-Tsai equations described previously, and compares those values with 
the highest modulus achieved using each type of HA reinforcement particle in the SF/HA/PLA 
composites. This chart also displays the effect particle orientation has on the modulus of the 
composites, where the filled-in points represent composites with particles that have an orientation 
of H = 0.4 (partially aligned) and the open points represent composites that have particles with an 
orientation of 0.002 (randomly distributed). As shown by this figure, the aspect ratio and orienta-
tion have significant effects on the final modulus of the composite material, where there is a direct 
correlation between the modulus and both aspect ratio and orientation of the reinforcement parti-
cles. Composites made using both types of HA described in this paper achieved moduli close to 
the calculated value, with both composite formulations reaching ~90% of the expected modulus 
for the respective HA used. 
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Figure 4.10: A plot of the calculated Young’s modulus vs. HA content of SF/HA/PLA composites fabricated 
as described in this study. Expected moduli using both polycrystalline HA nanorods and single crystal HA 
nanowhiskers are reported and compared with the highest observed moduli using both types of HA.  
 
4.3.3. IN VITRO DEGRADATION 
Figure 4.11 shows the mass loss of the composite samples over the 8-week incubation 
period. From the figure, it is apparent that the protease XIV causes the sample to degrade more 
quickly than when the degradation media is only PBS. During the 8-week incubation period, the 
group of samples in the media with protease XIV lost 4.9% of their total mass, while the group of 
samples with just PBS lost only 1.3% of their total mass. Using the aforementioned modified three-
point bending fixture, the stiffness (N/mm) and load to failure (N) of the composite samples were 
recorded after the samples were removed from the degradation media and dried overnight. Table 
4.2 shows that the stiffness and load to failure of the composites gradually decreased during the 
8-week degradation study. The control group, spending zero days in the degradation media, has 
a bending stiffness and strength of 94 N/mm and 254 N, respectively. After 8 weeks of degrada-
tion in just PBS, the bending stiffness and strength drop to 82 N/mm and 154 N, respectively. 
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However, when protease XIV is present in the degradation media, the stiffness and strength are 
83 N/mm 149 N, respectively. 
 
Figure 4.11: The in vitro degradation profile of the curved composite samples that were incubated in PBS 
and PBS + protease XIV for 8 weeks. 
 
Table 4.2: A summary of the in vitro degradation study, quantifying the effect degradation has on the 
bending properties of the composite bars. 
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4.3.4. IN VITRO CELL VIABILITY 
Figure 4.12a shows the results from the alamarBlue cell proliferation assay, in which there 
is a statistically significant increase in the reduction of alamarBlue until day 7. This increase in 
alamarBlue reduction indicates there is an increase in cell proliferation during the first 7 days of 
the study. However, on day 14 there is no statistical change in cell proliferation when compared 
to day 7. Figure 4.12b shows the overall cell viability on the composites is good, with there being 
a live:dead cell ratio of 19:1.  
 
Figure 4.12: The results from the cell proliferation assay using alamarBlue (a) and the cell viability assay 
using ReadyProbes blue/green kit (b). 
 
4.4. DISCUSSION 
Single crystal HA nanowhiskers were used as the particle reinforcement phase for the 
composites fabricated for this study. The unique morphology of these HA particles owes itself to 
the urea- and gelatin-assisted nature of the synthesis technique [152]. Urea decomposes when 
heated to 95 °C in the boiling flask, resulting in the pH rising to the point that calcium phosphates 
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can precipitate. The gradual rise in pH compared to other typical wet precipitation methods ena-
bles the slower, and more organized, growth of hydroxyapatite crystals. Furthermore, the pres-
ence of gelatin aids in the formation of single crystal nanorods of HA by acting as a coating for 
the HA via adsorption on the surface of the precipitate. Zhan et al. showed that gelatin has a 
strong electrostatic affinity [171] for the octacalcium phosphate (OCP) initially formed during this 
synthesis method and coats the particles longitudinally, thus only allowing crystal growth along 
the c-axis [172]. As mentioned, OCP is initially formed during this synthesis method, and gradually 
undergoes a single-crystal-to-single-crystal transformation into HA via heating for several days at 
95 °C. OCP is only stable in acidic environments [173], so with the gradual rise in pH via the 
decomposition of urea the OCP transforms into HA when incubated at high temperatures for long 
periods of time [172]. By limiting the crystal growth in the a and b directions, gelatin aids in this 
single-crystal-to-single-crystal transformation. During the transformation from OCP to HA, phos-
phate ions need to shift positions within the crystal and water in the OCP crystal is lost, which 
would create high internal stresses if the crystal were allowed to grow in the a and b directions, 
and would greatly limit the formation of single crystal HA. However, since the crystal grows pref-
erentially along the c-axis, the phosphate ions within the crystal only need to move a short dis-
tance and the internal stresses are kept low enough to allow for the transformation into single 
crystal HA. 
Although the gelatin plays a vital role in preserving the highly crystalline, rod-shaped mor-
phology of the HA, the thin coating of gelatin eventually has a detrimental effect on the composite 
properties. The gelatin layer promotes particle agglomeration and is known to have poor mechan-
ical properties [174], so in an effort to further boost the mechanical properties [175] gelatin was 
removed via an acetic acid wash. FTIR analysis confirmed that by stirring the HA nanowhiskers 
in a 0.5 M acetic acid solution, the gelatin can be dissolved from the surface of the HA particles 
and washed away with DiW. The sharp peaks in the XRD spectra before and after the acetic acid 
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treatment confirms the HA particles retain their high crystallinity [176]. Also, the FESEM images 
show the morphology remains the same, which is important in composite fabrication, as higher 
aspect ratio particles will have a better effect on the mechanical properties with regards to mod-
ulus and toughness [177]. 
To this end, the three-phase composites fabricated in this study, using these unique 
nanowhiskers achieved an average flexural modulus of 21.1 GPa, which is at the upper end of 
the 7-25 GPa range for natural bone that is reported in literature [178, 13, 12].  The composite’s 
average strength of 536 MPa far exceeds that of natural bone, which is generally reported to be 
up to 260 MPa [178]. This also places the composites in the lower end of reported strength values 
of surgical grade stainless steel [179]. To the best of the authors’ knowledge, 21.1 GPa and 536 
MPa also represent the highest modulus and strength values, respectively, reported for biore-
sorbable composites [147, 53, 59, 52, 62, 44]. Another important attribute of the composite ma-
terial made in this study is the failure mode during bending. Even though the composites possess 
great mechanical properties, if they failed catastrophically, they would be undesirable to be used 
in orthopedic applications.  As such, because they failed via fibrous failure, the composites can 
maintain mechanical integrity even after yielding. This failure mode owes itself to the unique 
nanowhisker reinforcement, as similar composites fabricated with low aspect ratio particles un-
derwent mode II delamination [149] and lost virtually all mechanical integrity after yielding [59, 
150]. The enhanced aspect ratio of the HA has a direct impact on the reinforcement efficiency of 
the HA nanowhiskers, which is a unitless value given to particles in particle-reinforced composites 
that typically depends on the aspect ratio of said particle [44]. As seen in the Halpin-Tsai equa-
tions in the supplemental materials section, an increase in aspect ratio causes a direct increase 
in reinforcement efficiency. This correlates to an increase in load transfer, as well as an increase 
in crack deflection and fiber pullout [36], both resulting in a significant increase in toughness com-
pared to the use of lower-aspect-ratio-particles [59]. Magnesium has been investigated for similar 
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uses as a load-bearing bone fixation device because of its great mechanical properties [66, 65] 
and its ability to degrade in vivo [64]. However, the degradation products (i.e. hydrogen gas) 
causes localized irritation and magnesium has been shown to degrade too rapidly in some in-
stances [70].  
The alignment of HA was determined using WAXS analysis of the entire composite mate-
rial. Due to the aspect ratio of HA nanowhiskers, and their single crystal nature [150, 152], the 
[002] plane of the HA crystal can be used to quantify the alignment of HA along the SF fibers 
[180]. Since the HA nanowhiskers grow along the c-axis of the particle, measuring the intensity 
of the [002] plane with respect to the azimuthal angle in the WAXS spectra will give an accurate 
quantification of the alignment of the particle within the composite. The results from this study 
show that the majority of particle alignment occurs as a result of the compression molding step 
during processing, shown in Table 4.1. This is likely due to the increase in shear flow of the PLA 
matrix due to the use of an open-ended mold for the compression molding, which allows for the 
excess matrix to flow in the direction of the long SF fibers out of the ends of the mold. It is well 
documented that shear flow can induce the alignment of particles [181], and typically an increase 
in the shear flow will increase the alignment. This is part of the explanation of the disparity of 
alignment between the pultrusion steps and the compression molding step, where the relatively 
high melt viscosity of PLA, when compared to the viscosity of the dip-coating suspension [182, 
183], results in a higher shear force on the particles and induces greater alignment. Furthermore, 
the high viscosity and highly directional flow in the compression mold suggest there will be mini-
mal movement after the particle undergoes partial alignment. However, some alignment that oc-
curs during the pultrusion step can be more easily undone because the organic solvent is still 
drying after the fibers exit the pultrusion die.  
As noted previously, the observed flexural modulus of the composites was lower than the 
calculated modulus using modified Halpin-Tsai equations (~10% lower). This is due primarily to 
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the nature of the SF fibers themselves. Since raw SF fibers come from silkworm cocoons [184], 
it is nearly impossible to achieve perfect fiber alignment. This slightly imperfect alignment is seen 
in Figure 4.7c. This slight misalignment is detrimental to the final mechanical properties of the 
composite along that same axis [36], where perfect fiber alignment would achieve the highest 
possible modulus of the composite.  
From Figure 4.10, it is apparent that the aspect ratio and orientation have an effect on the 
final modulus of the composites. The figure shows that using HA with an aspect ratio of 6 causes 
a slight decrease in modulus when there is 10 vol% present. This is largely because of the poor 
reinforcement efficiency of a particle with a low aspect ratio, as calculated from Equation 4.4 [95]. 
As more HA is added, the modulus increases to a value higher than composites with no HA. 
However it is worth reminding that if the HA content exceeds the 16 vol% (the formulation with 
the highest modulus, described previously), there is severe particle agglomeration and the ob-
served modulus falls significantly below the calculated modulus [59], which was the primary rea-
son for developing the high aspect-ratio, single crystal nanowhiskers. As previously mentioned, 
the nanowhiskers allowed for greater particle orientation due to the shear flow that is induced 
during compression molding, and higher aspect ratio also increased the reinforcement efficiency 
of the particle. Both of these factors caused an immediate increase in modulus with the addition 
of the nanowhiskers. Figure 4.10 further displays the benefits an increased aspect ratio, with 
calculated moduli for composites with HA nanowhiskers that possess an aspect ratio of 50, which 
is often considered the minimum aspect ratio needed to fully take advantage of the mechanical 
properties of the particle reinforcement phase in polymer-matrix composites [36].  
The in vitro degradation study revealed that protease XIV causes increased degradation 
of the composite samples when compared to only using PBS. This is expected because it is well 
documented that silk fibroin does not degrade hydrolytically in vitro; there must be an enzyme 
present in order for silk fibroin to degrade [150]. During the 8-week study, the composite samples 
 93 
lost 4.9% of their total mass, and, more importantly, remained intact and showed no signs of 
swelling. Due to this minimal swelling and minimal porosity observed during imaging, it was as-
sumed that the composites made in this study possessed negligible porosity. It has also been 
reported that pores can be eliminated when performing high-pressure compression molding, as 
performed here [185]. In vitro degradation of silk fibroin cannot be directly related to in vivo deg-
radation with regards to mass loss [58], however the concentration of protease XIV used in this 
study is known to enable accelerated degradation of SF [186], so it is more important that the 
composite samples retained their shape and structural integrity for the duration of the study. The 
study also revealed that after 8 weeks in the degradation media, the composite samples lost 11.7% 
of their original stiffness and 40% of their original load capacity. Bending stiffness is highly de-
pendent on the shape/size of the sample and the support span used during testing, which is why 
only the curved samples underwent bending stiffness tests because comparing those results to 
load vs. displacement curves for rectangular samples would be irrelevant. Stiffness of rectangular 
samples is known to be related to the thickness of the sample cubed [187]. As such, if the sample 
thickness was increased by just 50%, then the stiffness would be increased by more than 350%, 
so a small increase in thickness would make up for any lacking stiffness. The thickness of bone 
fixation devices typically range from 2-2.5 mm [164], and, as such, if the thickness of the compo-
sites in this study was increased to 2.5-3 mm, they would be able to maintain proper stiffness for 
the duration of healing [149]. The loss of strength over the 8-week degradation period is much 
more significant, but the samples still provide enough loading capacity because of the high 
strength at the start of the study. Before degradation, the composites have a bending strength of 
more than double that of natural bone [32], so a 40% loss after the 8-week study indicates that 
the composites still have a higher strength than that of natural bone. Also, as mentioned previ-
ously, this loading capacity can be dramatically increased by increasing the thickness of the com-
posites by a small margin.  
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The in vitro cell viability assays performed in this study showed the composites have good 
overall biocompatibility. The increase in reduction of alamarBlue shows that the cells increase in 
proliferation during the 14-day study [162]. Based on these results, the cells continue to proliferate 
until day 7, when they reach confluence, which is in accordance with similar cell proliferation 
studies found in literature [188]. The results from the cell viability assay show that cells attach well 
to the composite samples. Thus, the results collectively indicate that the composites support both 
MC3T3 cells attachment and proliferation. In Figure 4.12b, which shows the cells dyed with Nu-
cblue/Nucgreen, there appears to be small pieces of silk fibroin fibers that have absorbed some 
of the dye as well. These were determined to be fiber particulates based on the width of them 
matching the known width of silk fibroin (9-12 µm) [189], and they are present due to the process 
of making the small composite samples for the cell study. Using the aforementioned wet saw to 
cut the composites into smaller pieces gives rise to these small segments of fibers. However, all 
of the fibers still in the composite do not absorb the dye because of the thin layer of PLA that is 
present on the surface of the composite. This thin layer of PLA shields the fibroin fibers from 
absorbing the dye, allowing an accurate cell count to be obtained.  
4.5. CONCLUSIONS 
This study demonstrated the feasibility of making a totally bioresorbable bone fixation de-
vice that can be used for load-bearing bone fractures in vivo. The reported results show that a 
three-phase composite was fabricated using silk fibroin long fiber and hydroxyapatite nanowhisker 
reinforcement bound together with a polylactic matrix polymer. The final composite material pos-
sesses, to the best of the authors’ knowledge, the highest reported flexural modulus and strength 
with values of 21.1 GPa and 536 MPa, respectively. The achieved modulus matches that of nat-
ural bone, which will eliminate the occurrence of stress shielding and the need for a second sur-
gery to remove the implant. Furthermore, using a curved mold to press the composite, a functional 
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curved fracture fixation device was fabricated, with the curvature allowing the implant to contour 
to the fractured bone. This device underwent in vitro degradation and cell viability studies to as-
sess if the composite would be useable in an in vivo environment. The 8-week enzymatic degra-
dation study revealed that the composites have a slow degradation rate and maintain their shape, 
showing negligible swelling during the duration of the study. Subsequent flexural tests showed 
that the composite samples lost 11.7% of their original bending stiffness, which can be remedied 
with just a slight increase in the original thickness. The samples lost considerably more of their 
loading capacity during the 8-week study, losing ~40% compared to the 0-week time point, but 
this should not pose a problem because of the initially high loading capacity of the composites. 
Lastly, the two in vitro cell viability tests indicated that the composites have good biocompatibility. 
Using the reduction of alamarBlue approach, cells were shown to increase proliferation on the 
composites up to one week after initial incubation and plateauing after 7 days. Additionally, the 
ReadyProbes blue/green cell viability imaging kit showed that cells attached to the samples and 
there was minimal cell death during the 2-week study. The results presented here collectively 
suggest this composite material could provide a viable option for a load-bearing bone fixation 
device while remaining degradable in vivo, and future in vivo tests will be needed to confirm the 
findings here.  
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CHAPTER 5: CONCLUSIONS AND FUTURE WORK 
5.1. CONCLUSIONS 
This work has sought to address the gap in available bone fracture fixation devices on the 
market, where there are currently only two options, either metal or polymeric fixation devices. 
While metal devices have high mechanical properties and offer support to heal load-bearing bone 
fractures, they cause stress shielding and metal ion leaching, and often require a second surgery 
to remove the implant. However, polymeric fixation devices safely degrade in vivo, but the me-
chanical properties of such devices are too low to support the healing of load-bearing fractures. 
The ideal bone fracture fixation device would combine the positive aspects of both of the current 
solutions, resulting in a device that has mechanical properties suitable for supporting the healing 
of load-bearing bones while retaining the ability to degrade safely in vivo.  
Seeking to bridge said gap, this work outlines the development of a three-phase composite 
material that possesses mechanical properties needed to properly support bone and is composed 
of materials that are already FDA approved and are known to degrade safely in vivo. The compo-
site investigated here is composed of either PLLA or SF fibers, hydroxyapatite particles, and either 
a PLA or PCL low-temperature matrix, thus creating a composite with two phases of reinforcement 
(i.e. long fibers and particle reinforcement). Unique processing techniques were employed to fab-
ricate such a composite, utilizing solvent-based pultrusion and subsequent hot compression mold-
ing. Statistically designed experiments (DOE) were used to aid in the materials selection and 
initial composite formulations, where the final composite that will be used for future studies is 
composed of long SF fibers, hydroxyapatite nanowhiskers, and a PLA matrix. 
With regards to mechanical properties, the goal was to create a material that matched the 
modulus of natural bone (7-25 GPa), so as to prevent stress shielding, and have a strength greatly 
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exceeding that of bone (80-160 MPa). The progression of mechanical properties for the compo-
sites produced in this study is summarized in Table 5.1, where the beginning composite has a 
modulus and strength of 9.2 GPa and 187 MPa, respectively. The final composite material pro-
duced for this study exhibited a bending modulus and strength of 21.3 GPa and 531 MPa, respec-
tively. Both of the latter values represent the highest reported values for a bioresorbable compo-
site found in literature, with the modulus matching that of cortical bone and the strength reaching 
the lower range of the currently-used metal implants. Additionally, the composites demonstrated 
excellent toughness, failing via fibrous failure rather than brittle failure. WAXS was used to deter-
mine the orientation of HA within the composite, which was further used to estimate the modulus 
of the composite using modified Halpin-Tsai equations. From these equations, it was determined 
that the theoretical modulus for the composites was 23.2 GPa. This was similar to the observed 
modulus, with the minor disparity stemming from the slight misalignment of the natural SF fibers. 
 
Table 5.1: A summary of the mechanical properties of the composites fabricated for this study.  
 
 
  
The bone fixation composites produced here were also fabricated into functional fixation 
devices and analyzed with respect to their in vitro properties. Originally, the composites were 
fabricated into rectangular bars, which enabled three-point bending modulus and strength to be 
calculated and allowed for easy comparison with other materials investigated for similar uses. 
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However, these rectangular bars offer minimal usefulness with regards to fixating a bone fracture. 
As such, custom molds were made to fabricate curved bars that would contour to bones and 
enabled clean holes to be drilled into the sample (as is necessary to anchor the device to bone). 
These curved bars underwent in vitro enzymatic degradation and cell viability evaluations. The 
degradation study revealed that the samples degraded slowly via surface erosion. Subsequent 
bending stiffness tests showed that the samples retained 88% of their original stiffness and 60% 
of their original strength values. While a 40% drop in strength sounds high, the starting strength 
is high enough to mitigate this, and both reductions can be remedied by increasing the thickness 
of the devices by a small margin. In vitro cell proliferation tests showed that cells increased pro-
liferation on the devices over a one-week period and plateaued thereafter, as is common with 
such studies. Additionally, cell viability tests showed the cells retained a high live-to-dead cell ratio 
after two weeks, with a final ratio of 19:1 (live:dead). Such results indicate the composites should 
exhibit good biocompatibility in vivo.  
The data presented in this study represent a significant leap forward in the quest to pro-
duce a viable bioresorbable, load-bearing bone fixation device. The combination of materials used, 
mechanical properties, and in vitro properties suggest the composites fabricated for this study 
could provide the necessary attributes to be used as a fixation device in vivo. The following sec-
tions provide in insight into future work that should take place in order to further characterize and 
optimize the material for use in the clinical setting as a fracture fixation device.  
5.2. FUTURE WORK 
5.2.1. STIFFNESS OF FIXATION DEVICES 
As mentioned previously, while the modulus of the implant is important, especially when 
comparing to other work done on the development of degradable fixation devices, it is the overall 
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implant stiffness that really determines whether or not stress shielding will occur [32]. For this 
reason, in the future it would be important to consider the overall design of the fixation device to 
achieve the necessary stiffness for fixating the bone fracture. Despite reaching the upper range 
of moduli for natural bone, it is likely the overall stiffness of the devices made in this study will 
need to be increased in order to properly fixate bone [35].  The curved fixation devices fabricated 
in this study were designed entirely based on the design of current metal fixation devices. How-
ever, due to the increased biocompatibility and bioresorbable nature of these composites when 
compared to metal devices, liberties could be taken to increase the stiffness. Current metal de-
vices are designed to make the smallest amount of contact with bone tissue as possible because 
of early evidence of necrosis with prolonged use of metal plates in vivo [190] caused by the afore-
mentioned stress shielding and chronic metal ion leaching. This discovery led to the invention of 
limited contact plates, which are currently used today. This “limited contact” design is a necessity 
with metal plates and is made possible because of the excessively high stiffness of titanium and 
stainless steel [191]. With this in mind, the bioresorbable bone fixation devices produced in this 
study could be made larger (i.e. with a curvature that contours to the bone even more) with no 
risk of chronic tissue necrosis. Furthermore, the plates could be made slightly thicker than their 
metal counterparts. Based on the moment of inertia [192], which is used to calculate the stiffness 
of a device [193], increasing both the length of curvature (i.e. instead of making a plate with a 
radius of curvature of 12.7 mm and a width of 10 mm, you could increase the width to 15 mm) 
and the thickness of a semi-circular plate would significantly increase the stiffness of a fixation 
plate. Additionally, bone fixation devices could be added to both sides of the fracture site, rather 
than just one side, as is typically done currently, which would further bolster the fixation stiffness. 
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5.2.2. MECHANICAL PROPERTIES 
As previously mentioned, the composites in this study reached an average bending mod-
ulus of 21.3 GPa. This value matches or exceeds the modulus of most cortical bone (it falls in the 
upper range of 7-25 GPa), which is ultimately the goal of a fixation device, however, it would be 
ideal for such a material to hit the maximum 25 GPa modulus of bone. As discussed in a previous 
section, the bulk stiffness of the device can be increased greatly by a small increase in thickness, 
but it would be desirable to keep the thickness of the fixation device as small as possible. Increas-
ing the modulus of the composite material could be possible by employing HA particles with an 
even higher aspect ratio. To achieve optimal reinforcement efficiency in polymer matrix compo-
sites, the particle reinforcement should have an aspect ratio of ~50 [36]. Reaching this aspect 
ratio would increase the modulus of the matrix and, as such, increase the modulus of the entire 
composite, as shown in Figure 4.10. Such HA particles have been produced in literature [194], 
but so far these particles have been limited to quantities that are not feasible in the amounts 
needed for composite fabrication. 
Another option for increasing the mechanical properties of the composite could be the 
incorporation bioactive glasses (BG) as the long-fiber reinforcement. As the name suggests, BG 
are glasses that are known to stimulate bone tissue adhesion and regeneration, and typically 
forms a bond with bone that is too strong to remove the implant [195]. The highly bioactive nature 
of these glasses stems from the slightly-altered composition when compared to soda-lime glasses 
typically used to make windows, where bioactive glasses have less silica and more phosphorous 
and calcium [196]. Additionally, these glasses can be tailored to have varying degradation rates 
and possess relatively high flexural properties, achieving a modulus and strength as high as 64 
GPa and 1000 MPa, respectively [197]. However, there has been limited work done on producing 
fibers of such glasses, and the formulations of BG that have been made into fibers generally have 
fast degradation rates [198]. There has been some work at making composites using BG fibers 
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for the purpose of bone fixation devices [199], but the authors noted difficulties in achieving high 
packing fraction of BG fibers, yielding relatively low mechanical properties, and a fast degradation 
rate. Despite the short-comings of BG glass fibers for use in bone fixation composites thus far, 
the field of bioactive glasses is ever-expanding, and these fibers could prove useful for such com-
posites in the future. 
5.2.3. IN VIVO ANALYSES 
Given the overall positive results from the in vitro tests performed on the composite bars 
thus far, the next step for studying this material is to perform in vivo tests. Due to limitations on 
the composite processing, in vivo analyses would need to be conducted on a large animal model, 
where a rabbit would be the smallest practical animal. Due to the processing restrictions, it would 
not be possible to fixate the composites on a bone of an animal smaller than this. Also, in vivo 
tests would need to be completed with multiple time points. In vivo tests for similar products have 
been performed with time points up to 7 years post implantation, to ensure there is no long-lasting 
harmful effects of the fixation device. As such, it would be important to analyze how well the device 
promotes healing of the bone, how quickly the device degrades in vivo, and the long-term bio-
compatibility of the implant. These different aspects of bone fixation device functionality could be 
analyzed via histology at various time points, which would highlight bone healing and any possible 
necrosis or fibrous encapsulation. 
5.2.4. INTRAMEDULLARY RODS AND BONE FIXATION SCREWS 
While this project showed positive results with regards to developing a load-bearing bone 
fixation plate, it did not focus on the development of the other two general categories of fixation 
devices: intramedullary rods and fixation screws. Intramedullary rods should be relatively easy to 
fabricate using techniques similar to those outlined in this study, with a slight modification. Rather 
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than using pultrusion, a processing technique known as filament winding could be utilized. Fila-
ment winding is a composite fabrication technique that is common when making products that 
have a round cross-section, such as airplane hulls or ski poles. By exchanging the pultrusion die 
for a filament winding setup, similar composites could be made that would match the stiffness of 
bone and remain as strong as the metal rods used today.  
Fixation screws will also need to be developed that have mechanical properties suitable 
to be used in tandem with the composite devices. Unlike for fixation plates, the mechanical prop-
erties of the greatest interest for screws are shear modulus and shear strength. The composites 
produced by Shikinami et al. [50] proved to have superior shear properties than pure PLA/PLGA 
screws, however these would likely need to be improved further for use in load-bearing applica-
tions. These shear properties could be improved by using HA with a higher aspect ratio (i.e. the 
HA nanowhiskers presented in this study), since the composites made by Shikinami et al. were 
made with low aspect ratio HA particles. Another option would be to make screws out of regen-
erated silk fibroin, which has been reported on in a few journal articles. By combining HA with 
regenerated silk fibroin, shear properties nearing those of bone could be achieved. With either of 
these options, the degradation time of the screws would match the degradation time of the fixation 
device, allowing for uniform degradation of the entire system. 
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